A source-led directory connecting specific treatments and diagnostic services with German centers that document them on their official websites. This is not a ranking and does not predict whether a center will accept an individual patient.
809 verified service-to-center links are currently documented. Every connection requires an official specialist-service source; we separately verify whether the wider hospital publishes an international-patient pathway. Read our methodology →
Charité publishes a dedicated acoustic-neuroma pathway covering MRI and hearing follow-up, microsurgical treatment and stereotactic radiation, with interdisciplinary treatment decisions and radiosurgical techniques including CyberKnife and Gamma Knife for selected cases.
Freiburg's skull-base surgery service identifies vestibular schwannoma as the most common tumor of the cerebellopontine angle, describes surgical treatment and documents intraoperative monitoring of the auditory nerve, facial nerve and brain stem.
University Hospital Würzburg publishes a dedicated acoustic-neuroma program describing interdisciplinary surgical treatment, observation, radiotherapy, hearing-preserving approaches, a specialist clinic for newly diagnosed and follow-up patients, review of outside MRI studies and hearing testing.
DHZC documents advanced-heart-failure care including all forms of mechanical circulatory support and preparation for heart transplantation, with separate official information on VAD systems and transplant evaluation.
MHH documents a dedicated outpatient clinic for advanced to terminal heart failure that evaluates transplant waiting-list candidacy and indications for mechanical circulatory support and provides long-term transplant and VAD follow-up.
Heidelberg documents multidisciplinary heart-failure and heart-transplant care and separately describes long-term ventricular-assist strategies including bridge to recovery, decision, candidacy, transplant and destination therapy.
Augsburg's cardiac-catheter center explicitly lists atrial-fibrillation ablation using established and newer technologies together with ablation of complex atrial and ventricular arrhythmias.
DHZC publishes dedicated catheter-ablation services for atrial fibrillation and other arrhythmias, including radiofrequency, cryoablation and pulsed-field ablation technologies.
University Hospital Cologne publishes catheter-ablation treatment for paroxysmal and persistent atrial fibrillation within its specialist electrophysiology program.
UKD publishes right- and left-heart catheter ablation and specifically pulmonary-vein isolation / substrate modification for treatment of atrial fibrillation within its rhythmology service.
University Medicine Frankfurt documents catheter ablation for atrial fibrillation through its university heart-rhythm center, including current pulsed-field ablation technology used in clinical care.
UKE publishes dedicated catheter ablation for atrial fibrillation, including pulmonary-vein isolation using radiofrequency, cryoballoon and pulsed-field ablation technologies.
Heidelberg publishes dedicated catheter ablation for atrial fibrillation, including pulmonary-vein isolation with pulsed-field, cryoballoon and radiofrequency techniques.
Saarland University Hospital publishes a DGK-certified atrial-fibrillation center with catheter-ablation pathways including pulmonary-vein isolation and treatment of other atrial and ventricular arrhythmias.
Leipzig publishes catheter treatment of atrial fibrillation using radiofrequency and cryoablation together with complex three-dimensional mapping for selected arrhythmias.
Mainz's dedicated Rhythmology department states that atrial-fibrillation treatment, particularly catheter ablation, is one of its principal specialist focuses.
LMU Klinikum publishes dedicated catheter-ablation treatment for atrial fibrillation, including pulmonary-vein isolation using radiofrequency or cryoballoon techniques.
TUM Klinikum's rhythmology service explicitly provides catheter ablation for atrial fibrillation within its specialist arrhythmia program.
University Hospital Münster publishes a dedicated rhythmology service providing catheter ablation for cardiac arrhythmias, with specialist outpatient assessment and inpatient ablation pathways.
The Cologne Eye Clinic publishes a retinal-treatment service that explicitly includes intravitreal medication for age-related macular degeneration alongside retinal imaging and other retina therapies.
Freiburg's retinology service documents OCT, OCT angiography, autofluorescence and retinal angiography and lists clinical research focused on age-related macular degeneration.
UKE publishes dedicated AMD information covering dry and wet disease, OCT and angiographic diagnostics, monitoring and intravitreal anti-VEGF treatment for neovascular AMD.
Charité publishes a dedicated specialist outpatient clinic for amyotrophic lateral sclerosis and other motor-neuron diseases within its Department of Neurology, providing a focused route for diagnosis review and specialist ALS care.
Freiburg publishes a detailed ALS pathway covering clinical and EMG-based diagnosis, differential testing, riluzole, physiotherapy, occupational and speech/swallow therapy, respiratory support, gastrostomy and interdisciplinary cooperation with pulmonology, gastroenterology, palliative medicine and social services.
Heidelberg's DGM-certified neuromuscular outpatient clinic explicitly includes motor-neuron diseases in its clinical spectrum and provides detailed neurological and neurophysiological evaluation including ENG, EMG and related diagnostic testing, with interdisciplinary links across the university hospital.
Charité publishes dedicated memory-clinic services for dementia and cognitive disorders, including neuropsychological testing and CSF dementia biomarkers, and currently offers a separate indication clinic to assess whether patients with diagnosed Alzheimer’s disease may be suitable for lecanemab or related anti-amyloid treatment.
Freiburg documents a specialist Memory Clinic with neuropsychological and CSF diagnostics and reports providing outpatient lecanemab treatment for selected patients with early Alzheimer’s disease, supported by biomarker assessment and repeated imaging follow-up.
Heidelberg’s Department of Neurology publishes a dedicated outpatient clinic for neurocognitive disorders that diagnoses and treats impairments of memory, language, attention and spatial orientation, including neurodegenerative causes such as Alzheimer’s disease.
Heidelberg's Skull Base Center explicitly describes meningiomas arising from the sphenoid wing and extending into the optic canal, orbit or cavernous sinus, including the risk of visual loss. Its neurosurgery service documents individualized skull-base surgery with neuronavigation, intraoperative imaging, neuromonitoring and interdisciplinary radiation-oncology support, making it a directly documented fit for anterior clinoidal and optic-canal-region meningiomas.
DHZC Charité documents both TAVI and surgical aortic valve replacement, supporting multidisciplinary comparison of transcatheter and surgical treatment for severe aortic valve disease.
UKE documents a structural-heart program for valve disease together with transcatheter and surgical heart-valve pathways, supporting multidisciplinary assessment rather than a procedure-first approach.
Heidelberg University Hospital documents a DGK-certified TAVI program with multidisciplinary cardiology, cardiac surgery and cardiac anesthesia participation in valve procedures.
LMU Cardiology documents DGK certification as a TAVI Center for catheter-based treatment of aortic valve stenosis and a broader structural-heart program.
Charité publishes a specialist ataxia pathway that distinguishes hereditary from acquired disease and discusses spinocerebellar ataxias, Friedreich ataxia, immune/paraneoplastic ataxia, MSA-C and sporadic adult-onset ataxia.
Bonn publishes a dedicated Ataxia Clinic for acquired, sporadic and hereditary ataxias, with multidisciplinary case conferences involving neuroradiology, human genetics and the rare-disease center plus an inpatient ataxia complex-treatment pathway including physiotherapy, speech therapy and nutrition counseling.
Freiburg’s Movement Disorders Clinic explicitly includes ataxia, evaluates rare subtypes and provides broader diagnostics including neuropsychology and CSF testing with close cooperation with neuroradiology, nuclear medicine and human genetics.
Heidelberg provides specialist rare-neurogenetic and spastic-ataxia services, with clinicians focused on hereditary ataxias and access to neurological imaging, genetic records review and multidisciplinary neurodegeneration expertise.
DHZC documents a dedicated atrial-fibrillation pathway covering stroke-prevention assessment, rhythm-maintenance therapy, catheter ablation, risk-factor management and specialist rhythmology follow-up.
UKE documents individualized atrial-fibrillation care including cardioversion, medication, catheter ablation with multiple technologies and interdisciplinary stroke-prevention assessment through its LAA Board.
Heidelberg University Hospital publishes a dedicated atrial-fibrillation pathway and electrophysiology clinic using individualized medical and interventional treatment concepts including catheter ablation.
LMU documents university electrophysiology care for atrial fibrillation with catheter-ablation techniques and also lists left-atrial-appendage closure among its interventional stroke-prevention services for selected AF patients.
Charité has a dedicated clinical focus and university outpatient service for autoimmune encephalitis and paraneoplastic neurological syndromes, including anti-NMDA receptor, LGI1/CASPR2 and other neuronal-antibody-associated disorders with specialist treatment and follow-up.
Freiburg explicitly treats autoimmune encephalitis in its inflammatory-CNS neuroimmunology clinic, with first diagnosis, differential diagnosis, second opinions and immunotherapy escalation; complex cases can be discussed in its interdisciplinary Neuroimmunboard.
Heidelberg publishes a dedicated autoimmune-encephalitis pathway covering serum and CSF antibody diagnostics, MRI, EEG, tumor screening, stepwise immunotherapy with corticosteroids, IVIG and apheresis and specialist long-term follow-up.
University Hospital Augsburg publishes a dedicated obesity center offering laparoscopic sleeve gastrectomy, gastric bypass and omega-loop/minibypass after multidisciplinary assessment and long-term lifestyle planning.
University Hospital Bonn publishes a dedicated obesity and metabolic surgery program including sleeve gastrectomy and multiple gastric-bypass procedures, with interdisciplinary consultation and structured follow-up.
UKE publishes an interdisciplinary obesity-surgery pathway, including sleeve gastrectomy and gastric bypass, and directs international treatment requests to its International Office.
University Medical Center Leipzig publishes a dedicated bariatric-surgery program offering minimally invasive sleeve gastrectomy, Roux-en-Y gastric bypass, omega-loop bypass and selected revisional procedures with structured follow-up.
Charité provides certified neuromuscular care for muscular dystrophies and a cardiology program that specifically lists Becker muscular dystrophy among dystrophinopathies evaluated for cardiomyopathy and rhythm involvement.
Freiburg's DGM/EURO-NMD neuromuscular center provides pediatric and adult muscular-dystrophy diagnostics and longitudinal care with genetics, cardiology, pulmonology, orthopedics, rehabilitation and transition pathways appropriate to dystrophinopathies including Becker disease.
Heidelberg combines DGM-certified neuromuscular assessment with a human-genetics service that explicitly provides DMD/Becker deletion-duplication analysis and sequencing, supporting confirmation of dystrophinopathy and specialist follow-up.
Düsseldorf's Bladder Cancer Center documents cystoscopy, pathology and imaging, TUR/laser TUR, BCG and intravesical chemotherapy, robot-assisted radical cystectomy, perioperative chemotherapy, immunotherapy and an interdisciplinary tumor board.
Essen Urology publishes bladder-cancer management from TUR and BCG for selected non-muscle-invasive disease through radical cystectomy and urinary diversion for muscle-invasive disease.
Freiburg Urology publishes a dedicated bladder-cancer pathway covering CT/MRI and cystoscopy, TUR-B, intravesical chemotherapy, radical cystectomy with urinary diversion and robot-assisted surgery.
Heidelberg Urology publishes a dedicated bladder-cancer service including photodynamic diagnostics, endoscopic procedures, Da Vinci-assisted radical cystectomy and bladder-replacement options.
Düsseldorf explicitly lists compression syndromes of brain-supplying vessels, including vertebral-artery compression in Bow Hunter syndrome, within vascular neurosurgery. Its cranio-cervical junction program separately lists Bow Hunter syndrome, vascular imaging such as MRA/CTA/Doppler/cerebral angiography and individualized conservative or surgical treatment including decompression and stabilization when appropriate.
Charité documents diagnosis-first BPH care with conservative and medical treatment as well as transurethral options including ThuLEP, GreenLight vaporization, TUR-P, REZUM and selected prostate-artery embolization assessment.
Freiburg documents a dedicated BPH service and modern laser enucleation techniques including HoLEP and ThuLEP for symptomatic benign prostate enlargement.
Heidelberg documents BPH evaluation with prostate examination, PSA when appropriate, ultrasound, residual urine and uroflowmetry, plus medical and operative treatment including established transurethral approaches.
Charité describes a vascular neurosurgery program for cerebral aneurysms offering the operative and interventional treatment spectrum, including microsurgical clipping and bypass strategies for selected complex aneurysms.
Freiburg publishes a dedicated cerebral aneurysm pathway with CTA or angiographic assessment, microsurgical clipping and endovascular coil treatment selected through interdisciplinary discussion between neurosurgery and neuroradiology.
Heidelberg publishes an interdisciplinary neurovascular pathway for aneurysms and vascular malformations, including acute aneurysmal hemorrhage care and specialist second-opinion evaluation for incidental unruptured aneurysms.
Charité's vascular neurosurgery service documents cerebral AVMs within its neurovascular program and states that operative, interventional and radiosurgical AVM treatment options are available, with individualized specialist consultation for treatment selection.
Freiburg publishes a dedicated cerebral AVM program and describes interdisciplinary treatment with microsurgical removal, endovascular embolization and radiosurgery, including combined approaches selected according to AVM anatomy and symptoms.
Heidelberg publishes a dedicated AVM pathway describing MRI/MR angiography and DSA for treatment planning and a multidisciplinary AVM conference involving neurosurgery, neuroradiology, radiation oncology and neurology.
Freiburg publishes multidisciplinary brain-tumor and neurosurgery services that include biopsy, resection and specialist neuro-oncology review.
UKE Neurochirurgie publishes a dedicated neuro-oncology pathway for brain and spinal tumors and provides specialist brain-tumor consultation before and after surgery.
Heidelberg publishes a dedicated brain-tumor surgery program covering gliomas, meningiomas, brain metastases and other intracranial tumors with neuronavigation and intraoperative functional monitoring.
LMU Neurochirurgie publishes operative treatment of benign and malignant central-nervous-system tumors with microsurgical resection, neuronavigation, neuromonitoring and interdisciplinary neuro-oncology review.
Tübingen lists brain-tumor surgery, neuro-oncology and intraoperative imaging among the core specialties of its university neurosurgery department.
University Hospital Augsburg publishes a certified Breast Center offering the full spectrum of breast-cancer diagnostics and treatment, including surgery, reconstruction, systemic therapy and radiotherapy through its interdisciplinary cancer network.
Freiburg publishes a German Cancer Society-certified Breast Center within the Comprehensive Cancer Center Freiburg, with interdisciplinary diagnostics, breast-conserving and reconstructive surgery, radiotherapy, systemic treatment and psycho-oncology.
The NCT and Heidelberg University Hospital publish a certified interdisciplinary Breast Cancer Center covering diagnostics, surgery, radiotherapy, systemic therapy, genetics and psycho-oncology.
Saarland University Hospital publishes a certified interdisciplinary breast center integrating gynecology, breast imaging and oncology for breast-cancer diagnosis and treatment.
Leipzig publishes a dedicated Breast Cancer Center within its University Cancer Center, with breast-conserving and mastectomy surgery, systemic therapy, radiotherapy and multidisciplinary treatment planning.
UCT Mainz publishes a long-established certified Breast Center providing quality-assured multidisciplinary diagnosis and treatment for breast cancer.
University Hospital Augsburg publishes coronary bypass surgery using conventional, off-pump and minimally invasive MIDCAB techniques with individualized Heart Team treatment planning.
DHZC lists coronary artery disease and bypass surgery within its cardiothoracic and vascular surgery services and provides an International Patients route for planned treatment.
University Medicine Frankfurt publishes coronary artery bypass grafting as its standard surgical treatment pathway for selected patients with significant coronary artery disease.
UKE publishes conventional, off-pump and minimally invasive coronary bypass surgery within its university heart-surgery program.
Saarland University Hospital publishes coronary bypass surgery including total arterial revascularization, minimally invasive techniques and beating-heart operations within its full cardiac-surgery program.
Mainz publishes coronary bypass surgery with complete arterial revascularization, on-pump and off-pump approaches and hybrid revascularization combining minimally invasive bypass with PCI when appropriate.
LMU Klinikum publishes a dedicated coronary bypass surgery program for selected patients with complex coronary artery disease through its university cardiac-surgery clinic.
University Hospital Münster lists coronary bypass surgery among the principal clinical focuses of its adult cardiac-surgery department.
UKE's vascular outpatient clinic explicitly states that it manages rare and complicated cerebrovascular diseases and inherited vascular disorders including CADASIL, and also provides specialist advice for referring physicians.
Heidelberg lists rare neurovascular diseases, juvenile stroke and cerebral angiitis among the focus areas of its Center for Rare Neurological Diseases. Its published neurovascular outpatient standards also contain a specific CADASIL diagnostic pathway with clinical, MRI, family-history and genetic-testing criteria.
Uniklinik RWTH Aachen publishes a dedicated CAR-T program and specialist lymphoma/CAR-T consultation pathway within its hematology and oncology services.
Charité publishes a dedicated CAR-T coordination service for selected hematologic malignancies within its hematology and oncology departments.
University Hospital Bonn publishes a dedicated cell-therapy and stem-cell-transplantation center that provides CAR-T cell therapy for selected hematologic malignancies alongside autologous and allogeneic transplantation.
Cologne publishes a dedicated CAR-T program covering approved cellular therapies for lymphoma, leukemia and myeloma, with named CAR-T coordination contacts.
University Hospital Dresden explicitly lists CAR-T cells within its cellular-therapy program for malignant diseases of the blood-forming and lymphatic systems, alongside dedicated inpatient, outpatient and day-clinic follow-up pathways.
University Hospital Düsseldorf publishes CAR-T cell therapy as an established treatment within its hematology service for selected hematologic diseases including lymphomas and leukemias.
University Hospital Erlangen explicitly lists CAR-T cell therapy among the modern cellular therapies provided by Medical Clinic 5 and publishes a dedicated CAR-T consultation for evaluation and follow-up.
University Hospital Essen publishes a dedicated CAR-T cell therapy pathway within its hematology and stem-cell-transplantation clinic, including specialist monitoring and a named CAR-T coordination service.
Freiburg publishes a dedicated CAR-T treatment pathway within its hematology and oncology program and also provides an international-patient contact route.
UKE explicitly lists CAR-T cell therapy among the clinical focuses of its stem-cell transplantation and cell-therapy center for selected hematologic malignancies.
Heidelberg University Hospital publishes a dedicated CAR-T treatment pathway and specialist assessment process within its hematology and cellular-therapy program.
Saarland University Hospital publishes a cellular-therapy program in Internal Medicine I with CAR-T therapy for selected lymphoma patients and dedicated coordination for CAR-T treatment.
University Medical Center Leipzig explicitly lists CAR-T cell therapy within the treatment spectrum of its hematology and cell-therapy department.
University Medical Center Mainz publishes a dedicated center for cellular immunotherapy and stem-cell transplantation that provides CAR-T cell therapy for selected hematological malignancies and multidisciplinary follow-up.
LMU Klinikum publishes a dedicated CAR-T program with specialist treatment enquiries and inpatient monitoring pathways within Medical Clinic III.
University Hospital Münster publishes a dedicated CAR-T program within its hematology and bone-marrow-transplant center and states that CAR-T treatment has been performed there since 2019 for selected hematologic malignancies.
University Hospital Tübingen states that its ZZT provides modern CAR-T cell therapies for children and adults and offers all approved commercial CAR-T products as well as selected locally manufactured cellular products.
Ulm University Hospital states that CAR-T therapies are carried out in its hematology and transplant unit for selected hematological malignancies, and the unit is JACIE certified for CAR-T cell therapies.
University Hospital Würzburg lists a large immunotherapy program including CAR-T cells within its hematology and oncology department.
DHZC publishes an amyloidosis consultation within the Charité Amyloidosis Center for diagnosis and care of patients with cardiac amyloidosis.
UKE documents a dedicated cardiac amyloidosis clinic for suspected or confirmed ATTR cardiac amyloidosis, including extensive diagnostic assessment, treatment and genetic testing; suspected AL amyloidosis is directed primarily to hematology with cardiology co-management when needed.
Heidelberg publishes a dedicated amyloidosis cardiology clinic offering comprehensive cardiac diagnostics and inpatient evaluation when the clinical condition or transplant assessment requires it.
University Hospital Augsburg's radiology service explicitly lists cardiac MRI for ventricular function, scar and infarct assessment, stress ischemia, cardiomyopathies, valve-flow assessment and cardiac tumors.
DHZC publishes a dedicated cardiac MRI service covering ischemia assessment, cardiomyopathies and congenital heart disease, including stress-perfusion CMR.
University Hospital Bonn Radiology publishes cardiac MRI as a dedicated cardiovascular imaging procedure within its patient diagnostic service, alongside specialized cardiac CT and other modern cross-sectional imaging.
University Hospital Cologne publishes clinical cardiac MRI for ventricular function, myocardial viability, perfusion, inflammatory heart disease, valve disease and other cardiovascular indications.
UKD Radiology publishes the full spectrum of cardiac MRI, including stress cardiac MRI and assessment of cardiomyopathies, myocarditis, valve disease, ventricular function and other cardiac conditions.
The Frankfurt University Heart and Vascular Center explicitly lists cardiac MRI within its clinical heart and vascular diagnostic program at the Schiffercampus.
UKE operates an interdisciplinary cardiac-imaging center with dedicated cardiac MRI and certified cardiovascular imaging expertise.
Heidelberg University Hospital operates a dedicated cardiovascular imaging division with clinical cardiovascular magnetic resonance imaging (CMR) for cardiac diagnosis and treatment planning.
Saarland University Hospital publishes a dedicated cardiovascular cross-sectional imaging clinic using cardiac MRI and cardiac CT for structured non-invasive evaluation of heart disease.
Leipzig's cardiology department publishes a dedicated cardiac MRI service for non-invasive assessment of cardiac structure and function, including myocarditis and myocardial perfusion disorders.
Mainz publishes an interdisciplinary cardiac-imaging program with cardiac MRI for myocarditis, scar assessment, cardiomyopathies and stress-perfusion evaluation of coronary disease.
LMU Klinikum provides clinical cardiac MRI through its cardiovascular imaging service, including functional, tissue-characterization and stress-perfusion assessment for selected cardiac conditions.
TUM Klinikum's rhythmology outpatient service explicitly uses cardiac magnetic resonance imaging as part of specialist diagnostic assessment for patients with cardiac rhythm disorders and underlying structural heart disease.
University Hospital Münster operates a dedicated Heart MRI Center offering resting and stress cardiac MRI for non-invasive assessment of cardiac structure, function and a broad range of cardiovascular diseases.
Augsburg explicitly publishes carotid endarterectomy techniques and, when stenting is indicated, coordinated carotid stent implantation with neuroradiology.
UKE publishes an interdisciplinary carotid-stenosis pathway covering best medical therapy, carotid endarterectomy and carotid artery stenting with vascular surgery, neurology and neuroradiology input.
Saarland University Hospital's vascular surgery service explicitly treats carotid stenosis and works within an interdisciplinary vascular center with radiology and angiology for individualized operative or interventional planning.
Leipzig publishes individualized carotid-stenosis review with both operative and endovascular stent treatment discussed through an interdisciplinary carotid board involving neurology, neuroradiology and vascular surgery.
Mainz publishes reconstruction of the supra-aortic vessels and surgical removal of carotid plaque after diagnostic assessment of carotid stenosis.
Düsseldorf's orbital/skull-base program explicitly lists carotid-cavernous fistula as a vascular differential diagnosis for proptosis, visual loss and diplopia. UKD's interventional neuroradiology service treats dural fistulas and vascular malformations within the neurovascular center, providing the relevant endovascular treatment infrastructure.
Heidelberg's neuroradiology head-and-neck diagnostic pathway explicitly illustrates a Carotis-Cavernosus-Fistel on flow-sensitive MRI. Its vascular and interventional neuroradiology program also performs diagnostic angiography and catheter-based embolization of arteriovenous fistulas, supporting a direct diagnostic-to-interventional pathway for CCF review.
University Hospital Cologne publishes a dedicated cataract clinic and documents lens replacement with standard, toric and multifocal intraocular-lens options after ophthalmic assessment.
Erlangen lists cataract surgery, including femtosecond-laser-assisted cataract surgery, among the Eye Clinic's specialist services and publishes a dedicated cataract consultation pathway.
Freiburg documents small-incision cataract surgery, predominantly topical anesthesia and intraocular-lens planning including monofocal, toric and multifocal options within its university eye clinic.
UKE documents cataract assessment and surgery with replacement of the cloudy natural lens by an intraocular lens and describes standard and specialized lens options within its Eye Clinic.
Heidelberg's ambulatory ophthalmic surgery unit identifies cataract and lens surgery as a major focus and documents management of routine and complex cases with monofocal, toric, EDOF and selected multifocal lens strategies.
Heidelberg's Skull Base Center explicitly describes meningiomas arising from the sphenoid wing or skull base and extending into the cavernous sinus, optic canal and orbit. Its neurosurgery service documents individualized skull-base surgery with neuronavigation, intraoperative imaging, cranial-nerve neuromonitoring and close collaboration with radiation oncology, matching the multidisciplinary treatment requirements of cavernous sinus meningioma.
Charité documents cavernomas within its cerebrovascular-neurosurgery program and describes operative removal as the central treatment option for selected symptomatic lesions.
Freiburg's vascular-neurosurgery program documents cavernous malformations and microsurgical removal, including neuronavigation and intraoperative monitoring for difficult locations.
Heidelberg documents specialist evaluation of cerebral cavernomas, MRI-based planning and microsurgical resection when indicated, including functional mapping and monitoring for lesions in critical areas.
Heidelberg has a dedicated official treatment page for sinus and cerebral-vein thrombosis. It states that standard treatment is medical, especially heparin, and that severe cases can undergo minimally invasive mechanical recanalization with stent retrievers, aspiration and selected adjunctive techniques through its vascular/interventional neuroradiology service.
UKE's specialist neuroradiology consultation explicitly evaluates suspected dissections of head and neck vessels, unclear vascular findings and second opinions on abnormal CT/MRI, with interdisciplinary access to adjacent specialties.
Heidelberg's Center for Rare Neurological Diseases explicitly lists dissections of the brain-supplying vessels among its rare neurovascular treatment priorities and works with neuroradiology and other specialist disciplines for complex diagnosis and care.
Charité's DKG-certified gynecologic cancer center publishes comprehensive specialist care for cervical cancer together with surgical, targeted, immune-based and clinical-study options within its gynecologic-oncology program.
University Hospital Essen lists cervical carcinoma as a dedicated focus of its Gynecologic Cancer Center within the West German Cancer Center and participates in contemporary cervical-cancer treatment research.
Heidelberg publishes a dedicated cervical-cancer pathway distinguishing early-stage surgery from advanced-stage chemoradiation and brachytherapy, with sentinel-node and selected fertility-preserving approaches.
Charité documents a dedicated clinic and research program for Charcot-Marie-Tooth / hereditary motor and sensory neuropathy, combining clinical phenotyping, electrophysiology, human genetics, gait and movement analysis and multidisciplinary rehabilitation and orthopedic collaboration.
Freiburg combines neurological peripheral-nerve expertise with human-genetics testing pathways that explicitly include CMT1, CMT2 and HNPP, including PMP22 copy-number analysis and phenotype-directed gene panels.
Heidelberg's DGM-certified neuromuscular service evaluates hereditary and acquired polyneuropathies with comprehensive ENG/EMG and other neurophysiology, peripheral nerve and muscle imaging, laboratory assessment and interdisciplinary referral, supporting CMT diagnostic review and long-term planning.
RWTH Aachen's spinal neurosurgery section explicitly lists special surgical treatment for Arnold-Chiari malformation, spinal-cord malformations and syringomyelia, making it relevant for decompression and complex Chiari/syrinx second opinions.
Augsburg has a dedicated adult pathway covering hydrocephalus, Chiari malformation and tethered cord. The clinic explicitly states that adults with Arnold-Chiari malformation are treated with targeted microsurgical decompression to improve cerebrospinal-fluid flow and neurological symptoms.
Charité publishes a dedicated bile-duct-cancer pathway covering surgery for selected localized disease, chemotherapy plus immunotherapy for many unresectable cases, molecularly targeted treatment in selected tumors, and endoscopic biliary procedures including ERCP and stenting.
Freiburg's Comprehensive Cancer Center publishes malignant biliary tumors as a dedicated clinical pathway within its gastrointestinal tumor center, supporting interdisciplinary hepatobiliary oncology review rather than a generic cancer pathway.
Heidelberg's Liver Cancer Center explicitly treats cholangiocarcinoma and coordinates diagnosis and therapy through interdisciplinary hepatobiliary clinics and tumor boards spanning surgery, oncology, gastroenterology, radiology, nuclear medicine and radiation oncology.
Charité publishes a dedicated outpatient service for immune-mediated polyneuropathies including CIDP, GBS, MMN and related disorders, and asks patients to bring electrophysiological findings, MRI imaging, laboratory results and clinical reports for specialist review.
Freiburg documents a specialist clinic for autoimmune inflammatory diseases of the peripheral nervous system including CIDP and provides current clinical material covering electrophysiological confirmation, supportive CSF and imaging tests and established immunotherapy pathways.
Heidelberg's certified neuromuscular outpatient clinic treats a broad spectrum of polyneuropathies and provides detailed ENG, EMG and other neurophysiological testing with access to peripheral nerve MRI, laboratory evaluation and interdisciplinary review; the department also publishes CIDP-specific electrophysiology guidance.
Charité publishes a dedicated Headache Center for diagnostic classification and specialist treatment of complex headache and facial-pain disorders, and its current neurology program specifically includes cluster headache among contemporary headache-treatment topics.
Freiburg publishes a dedicated cluster-headache pathway describing the typical trigeminal-autonomic phenotype, oxygen and rapidly acting triptans for acute attacks and preventive medication when attack frequency is high.
Heidelberg’s neurological headache clinic explicitly treats cluster headache and other trigeminal autonomic headaches and provides further diagnostics and individualized treatment plans for therapy-resistant, unclear or complex headache disorders.
University Hospital Augsburg publishes a dedicated cochlear-implant program for children, adolescents and adults, including candidacy diagnostics, implantation and structured hearing rehabilitation.
University Hospital Dresden's international-patient service documents its Saxon cochlear-implant center, including preoperative audiology, implantation, speech development therapy and rehabilitation.
Erlangen's ENT department operates CICERO, a dedicated cochlear-implant center combining surgical treatment with audiology, therapy and long-term rehabilitation.
University Hospital Essen publishes a dedicated Cochlear Implant Center within its ENT department, while the hospital also operates a Foreign Patient Service for treatment enquiries from abroad.
MHH's German Hearing Center documents a dedicated cochlear-implant and implantable-hearing-device program covering diagnosis, implantation and follow-up.
Leipzig operates a dedicated Cochlear Implant Center with candidacy assessment, inpatient implantation, postoperative fitting and a longer-term hearing and communication rehabilitation pathway for children and adults.
University Medical Center Mainz publishes a cochlear-implant program with pre-implant audiologic assessment, implantation, inpatient initial fitting, speech/hearing training and subsequent outpatient device follow-up.
UKM operates a dedicated cochlear implant center for children and adults involving ENT, phoniatrics and pediatric audiology.
University Hospital Augsburg publishes a DKG-certified colorectal cancer center with coordinated gastroenterology, surgery, imaging, oncology and multidisciplinary tumor-board treatment planning.
Freiburg publishes a German Cancer Society-certified colorectal cancer center integrating colorectal surgery, oncology, gastroenterology, radiation oncology, endoscopy, genetics and stoma/continence care.
NCT Heidelberg publishes a dedicated interdisciplinary colorectal-cancer program involving gastroenterology, oncology, abdominal surgery, radiotherapy, radiology, nuclear medicine and pathology.
Saarland University Hospital's Department of General, Visceral, Vascular and Pediatric Surgery publishes German Cancer Society certification for its colorectal cancer center.
Leipzig lists a dedicated colorectal cancer center within its visceral-oncology network, combining gastroenterology, oncology, surgery and regular multidisciplinary tumor-board review.
Mainz publishes a German Cancer Society-certified Visceral Oncology Center that includes a certified colorectal cancer center and coordinates interdisciplinary medical and surgical treatment.
The German Heart Center at Charité publishes dedicated pediatric cardiology, congenital-heart surgery and catheter-intervention services.
The German Children's Heart Center at University Hospital Bonn publishes surgical treatment of the full spectrum of congenital heart defects in children, including neonatal and complex congenital cardiac surgery.
UKE publishes an integrated pediatric heart program combining pediatric cardiology, congenital-heart surgery and adult congenital-heart medicine, with dedicated care for children with congenital heart defects.
MHH documents a dedicated congenital-heart surgery program spanning infancy through adulthood, with surgical, interventional and long-term pediatric-cardiology pathways.
Heidelberg University Hospital publishes a dedicated pediatric cardiology and congenital-heart program with operative pathways for children with congenital heart defects through its children's center and pediatric cardiac-surgery cooperation.
Saarland University Hospital publishes a Children's Heart Center combining pediatric cardiology, interventional cardiology, intensive care, cardiac imaging and pediatric cardiac surgery for congenital and acquired heart defects.
University Medical Center Mainz publishes pediatric cardiology for children with congenital heart defects and a dedicated pediatric cardiac-surgery program treating congenital heart disease across age groups.
LMU Klinikum publishes pediatric cardiology for newborns, children, adolescents and young adults with congenital heart defects together with pediatric cardiac surgery covering the full spectrum of congenital heart malformations.
Charité documents corneal transplantation with posterior lamellar procedures such as DSAEK and DMEK as well as DALK for selected anterior corneal disease.
University Hospital Cologne documents DMEK and DALK pathways and operates a cornea bank for donor-tissue preparation, quality assurance and transplant coordination.
University Hospital Düsseldorf documents DMEK, DSAEK, DALK and penetrating keratoplasty within its anterior-segment service and operates the certified LIONS Cornea Bank NRW.
Erlangen publishes a dedicated corneal-transplantation service using DMEK, DSAEK and DALK as well as full-thickness keratoplasty, with a specialist cornea clinic and transplantation pathway.
Freiburg documents penetrating and lamellar keratoplasty, including DMEK/DSAEK, within its specialist corneal disease service.
UKE describes corneal transplantation as a main focus of its corneal-surgery program, operates its own cornea bank and offers lamellar transplantation including DMEK for selected endothelial disease.
Heidelberg has a dedicated corneal and transplant surgery unit with a LIONS cornea bank, DMEK for endothelial disease, and DALK or penetrating keratoplasty for selected stromal disease and ectasia.
University Hospital Augsburg publishes a dedicated cardiac-catheter center for coronary diagnostic and therapeutic procedures and a direct patient-registration route for coronary interventions.
DHZC publishes diagnostic left/right heart catheterisation, coronary angiography and advanced invasive coronary assessment across its cardiac catheter laboratories.
University Hospital Düsseldorf documents round-the-clock invasive coronary diagnostics including coronary angiography through its cardiac catheterization laboratories.
University Medicine Frankfurt's coronary-heart-disease pathway explicitly describes invasive coronary angiography as the catheter-based diagnostic procedure used to visualize coronary narrowing and guide treatment decisions.
UKE explicitly publishes coronary angiography for invasive visualization of the coronary arteries through its cardiac catheter laboratories.
Heidelberg's cardiac catheter laboratory explicitly lists left-heart catheter examination with coronary angiography among its diagnostic procedures.
Saarland University Hospital publishes the complete diagnostic spectrum of the coronary arteries, including quantitative coronary angiography, pressure-wire assessment, OCT and IVUS.
Leipzig's cardiac catheterization laboratory explicitly publishes coronary angiography using radial or femoral access together with intracoronary imaging and coronary-physiology assessment.
Mainz publishes diagnostic cardiac catheterization and coronary assessment within its invasive-cardiology program, including OCT, IVUS and physiological lesion assessment when required.
LMU Klinikum publishes diagnostic coronary angiography through its cardiac catheter laboratory as part of its invasive cardiology program.
TUM Klinikum publishes diagnostic cardiac catheter examination within its invasive-cardiology service for evaluation of coronary and structural heart disease.
University Hospital Münster publishes a dedicated cardiac-catheter diagnostics and interventional service for coronary artery disease, with scheduled catheter pathways and invasive coronary assessment within Cardiology I.
DHZC documents diagnosis and treatment of coronary heart disease across interventional cardiology and cardiac surgery, including PCI/stenting and coronary bypass surgery with joint specialist decision-making.
UKE documents coronary heart disease care with PCI, CABG/ACB surgery and hybrid approaches within its university heart and vascular center.
Heidelberg documents specialist cardiology follow-up for coronary heart disease together with a cardiac-surgery program covering the full spectrum of modern coronary bypass surgery.
University Hospital Augsburg explicitly publishes high-resolution cardiac CT with coronary CT angiography for detailed non-invasive visualization of the coronary arteries and plaque assessment.
DHZC publishes cardiovascular CT services for coronary and structural-heart imaging and explains the role of CT angiography in selected patients with suspected coronary disease.
University Hospital Cologne publishes non-invasive CT coronary angiography for direct assessment of the coronary arteries, coronary stenosis and suspected chronic coronary syndrome.
UKD Radiology publishes CT coronary angiography for non-invasive visualization of the coronary arteries, including coronary plaque analysis in appropriate patients.
The Frankfurt University Heart and Vascular Center explicitly lists coronary CT diagnostics within its clinical cardiovascular imaging program.
UKE explicitly publishes non-invasive coronary CT angiography for visualization of coronary arteries, stenoses and coronary anomalies within its cardiac-imaging program.
Heidelberg University Hospital explicitly publishes coronary computed tomography angiography (cCTA) for non-invasive visualization of the coronary arteries and treatment planning.
Saarland University Hospital's cardiovascular imaging clinic publishes cardiac CT as a non-invasive modality for detailed assessment of cardiac structures and coronary arteries.
Mainz publishes an interdisciplinary cardiac-imaging service offering CT coronary angiography with modern photon-counting CT technology for non-invasive coronary assessment in appropriately selected patients.
LMU Klinikum publishes non-invasive coronary CT for direct visualization of the coronary arteries and assessment of suspected coronary artery disease within its cardiovascular imaging program.
Augsburg's cardiac-catheter center publishes complex and high-risk coronary intervention, CTO reopening and advanced lesion-preparation techniques as part of its PCI program.
DHZC publishes PCI, drug-eluting stents, drug-coated balloons, intracoronary imaging and complex coronary-intervention services in its cardiac catheter laboratories.
UKD's cardiac catheterization service publishes a broad PCI program with multiple angioplasty and coronary-stent techniques, including treatment of complex coronary anatomy.
University Medicine Frankfurt documents routine percutaneous coronary intervention (PCI) for narrowed coronary arteries using modern stent technology and intravascular imaging within its cardiac-catheter program.
UKE publishes PCI and contemporary coronary-stent implantation, including complex coronary lesions and CTO treatment, within its interventional-cardiology program.
Heidelberg's cardiac catheter laboratory explicitly publishes PTCA, coronary stent implantation and advanced intracoronary diagnostics within its interventional-cardiology service.
Saarland University Hospital publishes modern invasive treatment of coronary disease using techniques including atherectomy, lithoplasty, drug-coated balloons and drug-eluting stents.
Leipzig explicitly lists percutaneous coronary intervention with balloon angioplasty, drug-coated balloons, rotablation, complex CTO/bifurcation interventions and drug-eluting stents.
Mainz publishes percutaneous coronary interventions including stenting, CTO treatment, rotablation and intracoronary imaging within its invasive-cardiology service.
LMU Klinikum explicitly lists percutaneous coronary intervention (PCI), stent implantation and advanced intravascular coronary diagnostics within its interventional-cardiology service.
TUM Klinikum explicitly publishes coronary stent implantation, drug-coated balloons and complex coronary intervention including CTO treatment within its invasive-cardiology program.
UKM's interventional cardiology service explicitly describes treatment of simple and complex coronary lesions using modern stent technologies, including CTO recanalization and physiology/imaging support such as FFR and IVUS.
Charité’s movement-disorders service explicitly treats atypical Parkinson syndromes including CBD and offers specialist differential diagnosis with MRI, PET/SPECT, CSF, neuropsychology and other selected tests according to the clinical question.
Freiburg documents diagnosis and treatment of atypical Parkinson syndromes including corticobasal degeneration and selected functional imaging that can help differentiate CBD, PSP and MSA from idiopathic Parkinson’s disease.
Heidelberg publishes a dedicated atypical-Parkinson clinic that explicitly includes corticobasal disease/CBS and provides specialist assessment within its neurodegeneration and movement-disorders section.
Charité's neurosurgical outpatient service explicitly lists craniopharyngiomas among skull-base tumors for operative consultation and postoperative care and offers second opinions. The pathway is supported by the wider university-hospital neuro-oncology, endocrinology, ophthalmology and radiation-oncology network.
Heidelberg's interdisciplinary Skull Base Center explicitly lists craniopharyngiomas among the intradural tumors it treats and combines neurosurgery with ENT, maxillofacial surgery and radiation oncology; Heidelberg also documents endoscopic endonasal skull-base surgery for selected craniopharyngiomas.
Charité operates a dedicated center for peritoneal metastases and explicitly documents cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC) for selected patients after multidisciplinary assessment.
University Medical Center Leipzig publishes a dedicated HIPEC/PIPAC center and explicitly describes cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy for carefully selected patients with localized peritoneal malignancy.
University Medical Center Mainz publishes a dedicated peritoneal-carcinomatosis consultation for HIPEC/PIPAC within its Department of General, Visceral and Transplant Surgery and documents participation in the German HIPEC registry.
Charité publishes a CyberKnife-based stereotactic radiosurgery pathway, including a same-day SRS program for selected patients with brain metastases.
Heidelberg Radiation Oncology publishes a dedicated CyberKnife stereotactic treatment service for selected intracranial and extracranial indications.
Mainz publishes intracranial and extracranial stereotactic radiotherapy, including single-session stereotactic radiosurgery, and uses HyperArc for highly precise treatment of multiple brain targets in selected patients.
Charité publishes movement-disorder and functional-neurosurgery pathways that include deep brain stimulation for selected patients.
Freiburg International Medical Services publishes a dedicated stereotactic and functional neurosurgery program for DBS and related procedures.
UKE Neurochirurgie explicitly publishes deep brain stimulation for Parkinson disease and other movement disorders and provides a dedicated stereotaxy and brain-stimulation clinic.
Heidelberg publishes a dedicated deep-brain-stimulation pathway with interdisciplinary screening, stereotactic electrode implantation and postoperative stimulator management.
Saarland University Hospital publishes a long-established stereotactic neurosurgery program with deep brain stimulation and dedicated neurological coordination for Parkinson and movement-disorder patients.
LMU's neurosurgery service publishes a dedicated functional-neurosurgery pathway that explicitly includes deep brain stimulation for movement disorders such as Parkinson disease and dystonia.
Tübingen publishes a dedicated deep-brain-stimulation pathway for Parkinson disease, tremor and dystonia, with specialist neurological assessment and functional neurosurgical implantation including robot-assisted techniques.
Cologne documents a dedicated intravitreal-injection service using VEGF inhibitors and corticosteroids for diabetic macular edema, with OCT and angiographic retinal diagnostics and repeated follow-up when needed.
Freiburg operates a dedicated retinology service with OCT, OCT angiography, autofluorescence and fluorescein angiography and documents clinical research in diabetic retinopathy.
UKE publishes a dedicated diabetic retinal-disease pathway covering OCT and fluorescein angiography and states that diabetic macular edema is primarily treated with intravitreal medication, with selected steroid and laser options.
Cologne documents retinal laser for diabetic retinopathy, intravitreal treatment for diabetic macular edema and OCT/angiographic retinal diagnostics within its retina services.
Freiburg's retinology service provides advanced retinal imaging and documents clinical research focused on treatment of diabetic retinopathy.
UKE publishes dedicated staging, diagnostics, laser, intravitreal treatment and selected vitreoretinal surgery pathways for diabetic retinal disease.
Charité publishes a specialist program for hereditary, secondary and unexplained cardiomyopathies that explicitly includes dilated cardiomyopathy, together with cardiogenetic assessment and team-based review.
Heidelberg publishes a dedicated DCM disease pathway and Cardiomyopathy Clinic covering cause-focused diagnosis, cardiac MRI, selected biopsy, ICD/CRT assessment and advanced heart-failure options when required.
Heidelberg Nuclear Medicine publishes Ga-68 DOTATOC somatostatin-receptor PET/CT for neuroendocrine tumors and uses receptor imaging as part of its theranostic pathway before PRRT.
Ulm Nuclear Medicine routinely lists Ga-68 DOTA-i-TATE PET/CT for neuroendocrine tumors and documents the same receptor-targeted pathway in its PRRT service.
Charité's DGM- and EURO-NMD-certified pediatric neuromuscular center treats muscular dystrophies and coordinates assessment of respiratory, swallowing and cardiac complications; the program also documents DMD clinical-study experience.
Freiburg describes Duchenne muscular dystrophy as a long-standing clinical focus within pediatric neuromuscular medicine and publishes current DMD clinical pathways, including a 2025 givinostat SOP for eligible ambulant patients and a structured DMD cardiac-surveillance SOP.
Heidelberg provides DMD-focused pediatric neuromuscular research and registry activity and an accredited human-genetics pathway for Duchenne/Becker muscular dystrophy using DMD-gene deletion/duplication analysis and sequencing, supporting molecular confirmation and specialist review.
UKD's vascular neurosurgery program explicitly lists dural AV fistulas among the cerebral and spinal vascular malformations it treats and is positioned for cases requiring comparison of microsurgical and interdisciplinary neurovascular options.
Heidelberg publishes a dedicated dural AV fistula pathway describing MRI, angiography and endovascular embolization, states that AV-fistula embolizations are performed weekly and combines neuroradiology with neurovascular neurosurgery for fistulas requiring multidisciplinary planning.
Charité publishes a movement-disorders service that includes dystonia and connects neurological assessment with functional neurosurgery and DBS for selected patients.
Freiburg documents stereotactic and functional neurosurgery for movement disorders including dystonia and an established DBS pathway with postoperative stimulation management.
Charité publishes specialist endometrial-cancer care within its DKG-certified gynecologic cancer center and states that it has been recognized as Germany's first ESGO Center of Endometrial Cancer of Excellence since 2017.
University Hospital Essen lists endometrial carcinoma as a dedicated focus of its Gynecologic Cancer Center and publishes risk-adapted surgical and adjuvant treatment information.
Heidelberg publishes an endometrial-cancer pathway covering biopsy, molecular classification, imaging, minimally invasive and robotic hysterectomy, sentinel-node assessment, radiotherapy and systemic treatment according to risk.
University Hospital Augsburg publishes a dedicated Endometriosis Center and specialist clinic within its university gynecology department, which provides medical and operative treatment of endometriosis.
Charité publishes a dedicated endometriosis consultation pathway for specialist evaluation and treatment planning.
UKE publishes a dedicated endometriosis clinic and states that its gynecology department offers the full spectrum of conservative and operative treatment options for endometriosis.
Heidelberg University Hospital publishes a dedicated Endometriosis Center with specialist assessment and conservative, minimally invasive and robot-assisted surgical treatment for selected patients, including complex deep-infiltrating disease.
Leipzig publishes a dedicated endometriosis clinic and states that, when surgery is indicated, even extensive endometriosis can routinely be treated with tissue-sparing minimally invasive keyhole surgery.
Mainz publishes a dedicated Endometriosis Center offering specialist assessment and the full spectrum of diagnostic and therapeutic measures, including operative treatment when appropriate.
LMU Klinikum publishes a certified highest-level Endometriosis Center providing individualized specialist treatment planning through its university gynecology department.
TUM documents an interdisciplinary endometriosis center offering medical, surgical and psychological care, including complex surgery when bowel, bladder or ureters are involved.
UKB documents comprehensive presurgical epilepsy diagnostics including high-resolution MRI, prolonged video-EEG and neuropsychology before a neurosurgical decision.
Freiburg publishes a specialist epilepsy-surgery pathway covering presurgical evaluation, invasive diagnostics and surgical treatment for selected drug-resistant epilepsy.
UKE Neurochirurgie explicitly documents epilepsy surgery including selective amygdalohippocampectomy, temporal or cortical resections and individualized surgery after interdisciplinary evaluation.
Heidelberg publishes presurgical epilepsy diagnostics and operative treatment for selected drug-resistant epilepsy when the seizure-generating region can be identified and safely treated.
LMU publishes a certified highest-level epilepsy-surgery center with presurgical evaluation, invasive EEG monitoring and individualized resective or disconnective epilepsy surgery for selected children and adults.
UKM documents structured presurgical evaluation for drug-resistant epilepsy and interdisciplinary review with neurosurgery before planned epilepsy surgery.
Tübingen operates an interdisciplinary epilepsy center and dedicated epilepsy-surgery clinic with presurgical evaluation including high-resolution MRI, routine and long-term video EEG, neuropsychological testing and individualized surgical planning.
Freiburg publishes a comprehensive epilepsy program covering medical treatment, video-EEG, imaging, neuropsychology, presurgical diagnostics, resective surgery and stimulation therapies for complex epilepsy.
Heidelberg publishes specialist epilepsy diagnostics and treatment including presurgical evaluation and operative treatment when drug-resistant focal epilepsy can be localized and treated safely.
LMU documents a high-level interdisciplinary epilepsy center with presurgical evaluation, invasive EEG and individualized surgical treatment for selected drug-resistant epilepsy.
The Cologne Eye Clinic documents vitrectomy among its retinal-surgery procedures and explicitly lists epiretinal membrane formation as an indication treated by vitreoretinal surgery.
Freiburg's retinology service documents advanced retinal imaging and lists epiretinal gliosis with functionally significant metamorphopsia among established macular-surgery indications.
UKE publishes dedicated information on epiretinal membrane diagnosis with fundus examination and OCT and describes vitrectomy with membrane peeling when surgery is indicated.
Charité publishes a dedicated esophageal-cancer pathway distinguishing adenocarcinoma and squamous-cell carcinoma and maintains current clinical research in esophageal cancer.
Freiburg documents a dedicated interdisciplinary esophagus and stomach clinic with specialist surgery, tumor-board review and multimodal treatment using chemotherapy or radiochemotherapy before surgery according to histology, location and stage.
Heidelberg publishes specialist esophageal-cancer treatment including minimally invasive esophagectomy and multimodal pathways with chemoradiation in selected disease settings.
University Hospital Bonn publishes a dedicated essential-tremor page covering medication, physiotherapy, selected botulinum-toxin treatment and DBS for severe treatment-refractory tremor within its stereotactic and functional neurosurgery program.
Freiburg publishes an interdisciplinary advanced movement-disorder service for essential tremor and documents both deep brain stimulation and MRI-guided focused ultrasound, allowing selected patients to be assessed across adjustable stimulation and incision-free lesion treatment pathways.
Heidelberg publishes a dedicated essential-tremor pathway and an interdisciplinary DBS selection process involving neurology, neurosurgery, neuropsychology, psychiatry and neuroradiology for patients with disabling tremor not adequately controlled by medication.
Augsburg publishes open, endovascular and hybrid treatment of abdominal and thoracic aortic aneurysms and dissections, including customized stent-graft solutions for complex anatomy.
DHZC publishes dedicated aortic-disease pathways covering conventional surgery and endovascular treatment, including TEVAR and EVAR terminology and follow-up.
UKE's German Aortic Center documents treatment of complex thoraco-abdominal and post-dissection aneurysms, including fenestrated and branched endovascular stent-graft techniques.
Saarland University Hospital publishes both minimally invasive stent-graft and open surgical treatment of abdominal and pelvic aortic aneurysms, including customized endovascular grafts for complex vascular anatomy.
Leipzig publishes endovascular aortic treatment with EVAR, TEVAR, fenestrated and branched stent-grafts and hybrid procedures for selected aneurysms and dissections.
Mainz publishes open and endovascular treatment across the entire aorta and visceral arteries within its university heart and vascular surgery service.
Charité's movement-disorders service explicitly describes Friedreich ataxia among hereditary ataxias and provides differential diagnosis for inherited, metabolic, immune and degenerative ataxia syndromes.
Bonn operates a dedicated Ataxia Clinic, explicitly identifies Friedreich ataxia as a major inherited ataxia and coordinates large multicenter ataxia cohorts and treatment research through the DZNE Clinical Ataxia Network.
Heidelberg has a dedicated hereditary-ataxia clinical pathway that explicitly includes Friedreich ataxia, specialist neurogenetic diagnosis, ambulatory care and inpatient evaluation when more extensive diagnostics or medication adjustment is needed.
Charité documents dedicated FTD expertise within its dementia and cognitive-disorders service, including a specific FTD clinic, neuropsychological and CSF evaluation, genetic counseling and molecular testing for hereditary FTD, plus participation in the GENFI network.
Bonn operates a dedicated Frontotemporal Dementia Clinic and rare-disease FTD center, providing FTD-specific neuropsychology, laboratory and CSF testing, MRI, PET, genetic diagnostics, neurological/psychiatric treatment and social-medical counseling.
Freiburg’s Memory Clinic documents specialist evaluation of rare dementia subtypes with neuropsychological testing and CSF diagnostics, together with treatment recommendations, longitudinal follow-up and clinical-study access.
Charité provides specialist neuromuscular and muscle-disease assessment, while its cardiology service explicitly lists FSHD among muscular dystrophies evaluated for possible cardiac involvement. This supports multidisciplinary review when an FSHD patient has diagnostic, functional or cardiac questions.
Freiburg's Neuromuscular Center coordinates adult and pediatric muscle-disease care with neurology, neuropediatrics, human genetics, cardiology, pneumology and rehabilitation, supporting specialist diagnosis and long-term multidisciplinary planning for hereditary muscular dystrophies such as FSHD.
Heidelberg's DGM-certified neuromuscular outpatient clinic evaluates hereditary myopathies and muscular dystrophies with clinical neurology, ENG/EMG, muscle MRI and selected biopsy and coordinates with cardiology, sports medicine and other specialties, providing an appropriate specialist pathway for FSHD diagnostic and functional review.
Charité documents Fuchs endothelial dystrophy as a principal indication for DMEK and maintains a dedicated corneal service with its own cornea bank and lamellar transplantation program.
Cologne documents Fuchs endothelial dystrophy as a DMEK indication and publishes specialist corneal-transplant pathways for endothelial failure.
Erlangen documents DMEK as a standard procedure for Fuchs corneal dystrophy and other endothelial disorders within its corneal-transplant program.
Freiburg documents advanced Fuchs endothelial dystrophy within its corneal-dystrophy service and describes DMEK as the layer-selective treatment used for endothelial dystrophies.
Heidelberg describes DMEK as standard therapy for cornea guttata in Fuchs endothelial dystrophy within its dedicated corneal and transplant surgery service.
Freiburg documents treatment of gallbladder and bile-duct carcinomas within its comprehensive cancer center and a specialist liver and biliary surgery service using multidisciplinary planning and hepatobiliary procedures.
Heidelberg publishes a dedicated gallbladder-carcinoma pathway and describes cancer surgery with removal of the gallbladder plus adjacent liver tissue according to tumor invasion, together with gastroenterology and hepatobiliary evaluation.
Charité publishes a dedicated gastric-cancer pathway with histologic classification, gastroscopy and biopsy, endoscopic ultrasound and CT staging, and multidisciplinary gastrointestinal oncology care.
Freiburg publishes an interdisciplinary esophagus and stomach clinic and GI tumor center with endoscopic and surgical gastric-cancer care, preoperative chemotherapy for selected advanced resectable tumors, reconstruction and specialist nutrition support.
Heidelberg publishes a multidisciplinary gastric-cancer pathway covering gastroscopy and pathology, endoscopic ultrasound and CT staging, selected endoscopic treatment, subtotal or total gastrectomy, lymph-node surgery and coordinated oncology care.
Freiburg lists GIST within its sarcoma center and documents molecular diagnostics, surgery and targeted systemic therapy through interdisciplinary oncology and visceral-surgery teams.
Heidelberg publishes a dedicated GIST pathway covering endoscopic and cross-sectional diagnostics, histology and mutation analysis, surgery, imatinib and multidisciplinary tumor-conference decisions.
University Hospital Augsburg explicitly lists glaucoma diagnosis and glaucoma surgery within its comprehensive ophthalmology service spectrum.
Freiburg publishes medication, laser and surgical glaucoma treatment pathways through its specialist Eye Center.
UKE publishes the full spectrum of modern glaucoma surgery, including minimally invasive procedures, filtering surgery and drainage implants when medication or laser treatment is insufficient.
Heidelberg University Eye Hospital publishes glaucoma as a major surgical focus and explicitly lists glaucoma operations within its ophthalmic operating-center program.
Leipzig documents glaucoma diagnosis and treatment including minimally invasive glaucoma surgery within its ophthalmology service spectrum and dedicated glaucoma clinic.
Mainz publishes a dedicated glaucoma center offering the full spectrum of glaucoma surgery, including trabeculectomy, minimally invasive glaucoma surgery, drainage implants and combined procedures.
LMU Klinikum publishes a dedicated glaucoma clinic and a broad surgical spectrum including MIGS, trabeculectomy, drainage implants and other pressure-lowering procedures selected according to glaucoma type and severity.
Freiburg publishes a dedicated neuro-oncology center for brain tumors with interdisciplinary brain-tumor conferences, neurosurgery, radiation oncology, medical oncology, molecular diagnostics, chemotherapy and clinical-trial access.
Heidelberg University Hospital publishes a multidisciplinary neuro-oncology center for brain tumors with molecular stratification, neuropathology, neuroradiology, neurosurgery, radiation oncology and active clinical studies including current glioblastoma trials.
Heidelberg's interdisciplinary Skull Base Center explicitly lists rare glomus tumors among the diseases it treats. Heidelberg Neuroradiology also specifically describes MRI evaluation of glomus tumors/paragangliomas and catheter embolization of their vascular supply when useful before surgery, providing a directly documented diagnostic, embolization and skull-base treatment pathway.
Freiburg explicitly lists glossopharyngeal neuralgia among common vascular cranial-nerve compression syndromes and describes microvascular decompression (Jannetta) as the preferred surgical approach when medical treatment is unsuccessful.
University Hospital Augsburg publishes a DKG-certified Gynecologic Cancer Center and states that its gynecology department performs the full range of gynecologic cancer operations together with chemotherapy and systemic therapies.
UKE publishes a certified Gynecological Cancer Center for ovarian, uterine, cervical, vulvar, vaginal and other gynecologic malignancies, including specialist diagnostics and surgical treatment.
Heidelberg University Hospital publishes a certified gynecologic cancer center covering ovarian, uterine, cervical, vulvar and vaginal cancers with multidisciplinary and specialist surgical treatment pathways.
Leipzig's university gynecology service documents surgical treatment across gynecologic cancers and a dedicated Gynecologic Cancer Center covering ovarian, uterine and cervical cancers within the University Cancer Center Leipzig.
Mainz publishes a certified Gynecologic Cancer Center for cancers of the female reproductive organs, combining specialist surgical and systemic treatment from diagnosis through follow-up.
LMU Klinikum publishes a dedicated Gynecologic Cancer Center providing diagnosis, surgery, systemic treatment and follow-up for gynecologic malignancies within its comprehensive cancer-center structure.
Charité publishes a German Cancer Society-certified Head and Neck Tumor Center covering oral cavity, pharyngeal, laryngeal, salivary-gland and other head and neck malignancies through collaborating ENT, maxillofacial surgery, oncology, radiology, pathology and radiation-oncology departments.
Freiburg publishes a certified multidisciplinary Head and Neck Tumor Center with surgical, radiotherapy and drug treatment plus voice, swallowing and psychosocial support and weekly interdisciplinary tumor-board review.
Heidelberg's German Cancer Society-certified Head and Neck Cancer Center integrates ENT, oral and maxillofacial surgery, medical oncology and radiation oncology and publishes surgery, reconstruction, precision radiotherapy and systemic treatment pathways.
DHZC documents comprehensive evaluation for advanced and end-stage heart failure, including multimodal diagnostics, assessment for mechanical circulatory support and heart transplantation when clinically appropriate.
UKE publishes a dedicated heart-failure outpatient clinic and Heart Failure Unit with medical heart-failure treatment, transplant assessment and mechanical circulatory-support pathways.
Heidelberg documents a supraregional multidisciplinary heart-failure center with heart-failure and transplant clinics, VAD service and a dedicated Advanced Heart Failure Unit.
LMU publishes a dedicated heart-failure clinic providing etiologic assessment and individualized medical and interventional treatment, with heart transplantation and artificial-heart support available for selected severe cases in cooperation with cardiac surgery.
University Hospital Augsburg publishes minimally invasive aortic, mitral and tricuspid valve reconstruction and replacement, with Heart Team selection between surgical and catheter-based approaches.
DHZC publishes surgical heart-valve services alongside catheter-based structural-heart interventions, allowing specialist teams to compare surgical and transcatheter options.
UKE publishes surgical mitral-valve reconstruction and minimally invasive aortic-valve replacement alongside its transcatheter valve program.
Saarland University Hospital publishes reconstructive surgery for aortic, mitral and tricuspid valves and minimally invasive surgical valve replacement within its comprehensive cardiac-surgery service.
Mainz publishes surgical aortic-valve replacement and reconstruction together with minimally invasive valve surgery and other cardiac-surgical treatment through its university Heart Center.
LMU Klinikum publishes surgical heart-valve reconstruction and replacement, including minimally invasive approaches, within its university heart-surgery program.
University Hospital Münster publishes heart-valve surgery and minimally invasive cardiac surgery as core services within its adult cardiac-surgery program, supported by an interdisciplinary valve clinic.
Düsseldorf's vascular neurosurgery service explicitly lists hemifacial spasm among vessel-nerve conflicts, while Neurology's Botulinum Toxin and Spasticity Clinic lists hemifacial spasm among standard injection indications. The combination supports both symptomatic injection treatment and specialist MVD review.
Freiburg describes facial spasm as a common vascular cranial-nerve compression syndrome, with microvascular decompression as the surgical concept and botulinum toxin as an alternative. Its Neurology Botulinum Toxin Clinic also explicitly treats hemifacial spasm.
Charité documents transarterial chemoembolization specifically for hepatocellular carcinoma within its minimally invasive liver-tumor therapy service and conducts clinical research in locoregional HCC treatment.
Freiburg publishes a dedicated HCC program and current clinical pathway with interdisciplinary tumor-board selection across surgery, RFA/MWA, TACE, TARE/SIRT, SBRT and systemic treatment.
The Heidelberg Liver Cancer Center coordinates HCC care through interdisciplinary liver-tumor clinics and hepatobiliary tumor boards spanning surgery, oncology, gastroenterology, radiology, nuclear medicine and radiation oncology.
Bonn's rare movement-disorders center explicitly covers spasticity and hereditary neurological disease and participates in an HSP registry, supporting specialist diagnosis, longitudinal assessment and research-oriented second opinions.
Freiburg provides neurological gait/spasticity assessment and neurogenetic diagnostics for hereditary spastic paraplegia, with documented HSP-related genes including SPAST, ATL1, SPG7 and CYP7B1 and specialist services for spasticity treatment where indicated.
Heidelberg operates a dedicated outpatient clinic for hereditary spastic paraplegia and spastic ataxia within its rare-neurogenetic and neurodegeneration service, including genetics review, MRI-based differential diagnosis and individualized treatment planning.
Charité's neurology amyloidosis clinic explicitly evaluates familial amyloid polyneuropathies including hereditary transthyretin amyloidosis and provides specialist diagnostics for peripheral and autonomic nerve involvement.
Heidelberg's dedicated Neurology Amyloidosis Clinic is part of an interdisciplinary amyloidosis center and has a long-standing focus on familial transthyretin amyloid polyneuropathy, with neurological staging coordinated with MR neurography, cardiology and other specialties.
Würzburg's interdisciplinary amyloidosis center explicitly manages ATTR amyloidosis and brings together neurology, cardiology, hematology, hepatology, nuclear medicine and pathology for amyloid typing, neurological and cardiac staging and targeted treatment planning.
Freiburg explicitly documents lumbar disc herniation treated with minimally invasive or microsurgical decompression and separate cervical disc-herniation pathways with decompression, disc prosthesis or fusion depending on anatomy.
UKE documents an interdisciplinary University Spine Center covering degenerative disease and a Neurosurgery department that explicitly treats degenerative spinal herniation with modern minimally invasive and image-guided techniques.
Charité publishes hip and pelvic surgery pathways that include joint-preserving procedures, arthroscopy and hip endoprosthetics, supporting specialist review before choosing replacement.
UKE publishes a dedicated hip-and-knee endoprosthetics consultation that evaluates whether implantation is already necessary and lists osteoarthritis among the conditions treated.
Charité's Centrum for Musculoskeletal Surgery explicitly lists hip surgery including endoprosthetics and provides dedicated hip-surgery and hip-arthroplasty consultations.
UKE publishes dedicated hip and knee endoprosthetics consultations for primary joint replacement and problems with existing implants.
Heidelberg University Hospital publishes a maximum-care endoprosthetics center for primary and revision hip replacement, including complex deformity, implant failure and infection-related revision care.
Saarland University Hospital publishes a maximum-care endoprosthetics center with specialist hip-replacement and revision services for osteoarthritis and other joint disease.
Leipzig publishes a maximum-care endoprosthetics center for primary and revision hip and knee replacement, with interdisciplinary support for complex endoprosthetic procedures.
University Medical Center Mainz lists hip arthroplasty and revision arthroplasty within its certified maximum-care endoprosthetics program and orthopedic treatment spectrum.
LMU Klinikum publishes a certified maximum-care endoprosthetics program covering primary and revision hip replacement, including complex deformity and failed-prosthesis cases.
University Hospital Cologne explicitly publishes Holmium Laser Enucleation of the Prostate (HoLEP) as an operative treatment option for benign prostate enlargement.
University Hospital Düsseldorf explicitly publishes Holmium Laser Enucleation of the Prostate (HoLEP) for benign prostate enlargement within its operative urology service.
University Medicine Frankfurt Urology explicitly identifies holmium laser enucleation of the prostate (HoLEP) as a principal minimally invasive surgical treatment for benign prostatic hyperplasia within its BPH program.
Freiburg publishes HoLEP and related laser-enucleation techniques for selected patients with benign prostate enlargement.
UKE publishes a dedicated Holmium Laser Enucleation of the Prostate (HoLEP) patient page and describes routine use of the procedure for benign prostate hyperplasia.
LMU Klinikum publishes a dedicated Holmium Laser Enucleation of the Prostate (HoLEP) program for benign prostate enlargement and explicitly uses HoLEP as a standard operative pathway.
Charité publishes a dedicated chorea clinic that specifically treats familial neurodegenerative choreatic disorders including Huntington’s disease and provides neurological and neuropsychological assessment, genetic testing and access to in-depth genetic counseling.
Freiburg publishes a dedicated Huntington disease pathway covering genetic diagnosis and counseling, symptomatic treatment of movement and psychiatric symptoms, nutrition, physiotherapy, speech and occupational therapy and access to Huntington research networks and clinical studies.
Charité publishes a specialized cardiomyopathy program for hereditary, secondary and unexplained cardiomyopathies, explicitly including hypertrophic cardiomyopathy and obstructive HCM/HOCM.
UKE documents a dedicated HCM clinic for suspected or familial HCM, unclear ventricular thickening, initial diagnosis, second opinion, advanced therapy and clinical risk stratification.
Heidelberg publishes a dedicated HCM/HOCM disease pathway, cardiomyopathy outpatient clinic and transcoronary septal-hypertrophy ablation (TASH) pathway for selected obstructive cases.
Charité Neurology publishes a specialist outpatient clinic for idiopathic intracranial hypertension, secondary intracranial hypertension and intracranial hypotension, with dedicated clinical and research activity in IIH.
Freiburg publishes a dedicated English-language IIH pathway covering papilledema, MRI and venous imaging, lumbar-puncture opening pressure, exclusion of secondary causes, medical and weight-management treatment and interdisciplinary consideration of stenting, shunting or optic-nerve-sheath fenestration.
Heidelberg's vascular and interventional neuroradiology service publishes a specific pathway for venous sinus stenosis associated with raised intracranial pressure, including MR venography, catheter angiography with pressure-gradient measurement and selected balloon dilation or stenting when severe or progressive visual deterioration persists despite medical therapy.
University Hospital Erlangen publishes a dedicated fertility center offering IVF, ICSI, natural-cycle IVF/ICSI, intrauterine insemination, blastocyst culture, cryopreservation and related reproductive-medicine services.
Heidelberg University Hospital publishes a dedicated fertility service and explicitly lists insemination, IVF, ICSI, IVM, blastocyst culture and related assisted-reproduction techniques among its current treatment options.
University Medical Center Mainz publishes a dedicated fertility center with IVF, ICSI, intrauterine insemination, natural-cycle ICSI and related reproductive-medicine services selected according to the individual diagnostic findings.
LMU Klinikum publishes a university fertility center offering a staged assisted-reproduction pathway from cycle monitoring and intrauterine insemination through IVF and ICSI with blastocyst culture, together with fertility diagnostics and cryopreservation services.
University Hospital Münster publishes a reproductive-medicine and andrology pathway for fertility treatment including intrauterine insemination, IVF and ICSI, with cryopreservation services and specialist fertility assessment.
Bonn has a dedicated SBMA/Kennedy disease page and explicitly accepts patients with SBMA or suspected SBMA for further diagnostics, genetic counseling and medical care through its Motor Neuron Disease Clinic; it also offers second opinions.
Freiburg's neuromuscular clinic evaluates genetic and acquired neuromuscular disease with ENG/EMG, muscle and nerve imaging, laboratory testing, genetics and interdisciplinary review; its neuromuscular program also includes motor-neuron disease and neurogenetics. It is listed as a broad specialist second-opinion center rather than a dedicated SBMA program.
Heidelberg's DGM-certified neuromuscular clinic explicitly covers motor-neuron diseases and provides neurological examination, ENG/EMG and broad neuromuscular differential diagnostics. It is included as a verified motor-neuron/neuromuscular second-opinion center, not as a dedicated SBMA clinic.
Charité publishes a dedicated keratoconus pathway with corneal topography, cross-linking for progressive disease and DALK or penetrating keratoplasty for advanced cases when glasses or contact lenses are no longer adequate.
Cologne publishes a dedicated keratoconus center with corneal diagnostics and follow-up, rigid and scleral contact-lens options, corneal UV cross-linking with riboflavin, DALK and full-thickness corneal transplantation when clinically necessary.
Düsseldorf documents a specialist corneal program with keratoconus diagnostics and corneal collagen cross-linking research and treatment pathways, alongside DALK and other corneal-transplant techniques for advanced ectatic disease.
Erlangen documents keratoconus as a corneal-shape disorder treated within its specialist corneal-transplant program and describes DALK as a layer-selective option that preserves the patient's own endothelium in suitable cases.
Freiburg publishes a corneal service for keratoconus and a dedicated cross-linking pathway using riboflavin and UV light, with repeated corneal measurements used to assess progression and suitability for treatment.
Heidelberg publishes a dedicated keratoconus clinic and offers corneal cross-linking and CAIRS within its refractive-surgery service, with corneal transplant expertise available through the affiliated corneal and transplant surgery unit.
Charité documents a dedicated kidney-stone service using ESWL, ureterorenoscopy with stone fragmentation or removal, and percutaneous renal stone treatment, with a separate nephrology stone clinic for recurrent or severe stone disease.
Cologne documents a dedicated endourology and stone program with CT/ultrasound diagnostics, ureteroscopy and percutaneous renal stone removal, including laser-based endourology and metabolic stone care.
Freiburg documents CT/ultrasound-based stone diagnostics together with ESWL, URS and PCNL, followed by recurrence-prevention and follow-up planning.
Düsseldorf Urology publishes a dedicated renal-tumor pathway describing staging with CT and surgical treatment including organ-preserving partial resection and minimally invasive kidney surgery in selected patients.
Freiburg publishes a dedicated renal-cell-carcinoma pathway covering CT/MRI and biopsy, partial and radical nephrectomy, ablation, targeted therapy and immunotherapy within its urologic-oncology service.
Heidelberg Urology publishes integrated urologic-oncology care within NCT and documents kidney-preserving and robotic renal surgery, including complex kidney malignancies.
University Hospital Augsburg lists urolithiasis treatment with ESWL, endoscopic techniques, laser lithotripsy and percutaneous nephrolitholapaxy including mini-PCNL.
University Hospital Bonn publishes ureterorenoscopy with laser lithotripsy and percutaneous nephrolitholapaxy (mini-PNL / maxi-PNL) for urinary-stone treatment.
UKD's operative urology spectrum explicitly includes ureterorenoscopy, laser lithotripsy and percutaneous nephrolithotripsy for urinary-stone treatment.
Freiburg publishes minimally invasive and laser-based urologic surgery for kidney and ureteral stones.
UKE publishes a dedicated urinary-stone pathway with minimally invasive stone removal including ureterorenoscopy (URS), mini-percutaneous nephrolitholapaxy and extracorporeal shock-wave lithotripsy where appropriate.
Heidelberg University Hospital publishes endoscopic stone treatment using ureteral and renal access, holmium-laser stone fragmentation and minimally invasive removal of large renal stones.
Leipzig publishes a comprehensive stone-treatment program including ureteroscopy, laser lithotripsy, percutaneous nephrolithotomy including mini-PCNL, and extracorporeal shock-wave lithotripsy.
LMU Klinikum publishes a dedicated urolithiasis pathway with specialist kidney-stone consultation and operative treatment including ureterorenoscopy, laser stone treatment, PCNL and selected ESWL.
Charité publishes knee-replacement selection criteria, including partial replacement for selected compartment-limited osteoarthritis with suitable ligament function and alignment.
UKE publishes a dedicated hip-and-knee endoprosthetics consultation that evaluates whether implantation is already necessary and lists osteoarthritis among the conditions treated.
Charité's musculoskeletal center lists knee surgery including endoprosthetics and offers dedicated knee-arthroplasty consultations for patients requiring specialist assessment.
UKE publishes dedicated hip and knee endoprosthetics consultations for primary joint replacement and revision-focused assessment.
Heidelberg's maximum-care endoprosthetics center explicitly treats primary and revision knee arthroplasty, including complex and failed-prosthesis cases.
Saarland University Hospital publishes primary and revision knee arthroplasty within its orthopedic endoprosthetics program, including complete knee replacement and revision procedures.
Leipzig's maximum-care endoprosthetics center documents primary and revision knee replacement within its interdisciplinary joint-replacement program.
Mainz publishes a dedicated knee arthroplasty and revision arthroplasty service with individualized implant selection and treatment of complex failed or infected knee prostheses.
LMU Klinikum publishes a certified maximum-care endoprosthetics service covering primary and revision knee replacement within its university musculoskeletal center.
Charité's specialist myasthenia service explicitly includes Lambert-Eaton myasthenic syndrome and supports differential diagnosis, electrophysiology, antibody testing and treatment review for disorders of neuromuscular transmission.
Freiburg's specialist neuroimmunology and neuromuscular service includes myasthenic syndromes such as LEMS and can coordinate neurophysiology, antibody diagnostics, symptomatic therapy and immunotherapy questions.
Heidelberg's neuromuscular service covers myasthenic disorders including Lambert-Eaton syndrome and provides specialist neurological and electrophysiological assessment for complex neuromuscular-junction disease.
University Hospital Augsburg explicitly lists interventional left atrial appendage closure for stroke prevention among its structural catheter procedures.
DHZC lists minimally invasive closure of the left atrial appendage among its structural-heart interventional services.
The UKD interventional-cardiology service explicitly lists catheter-based left atrial appendage (LAA) closure among its structural-heart procedures.
The University Heart and Vascular Center Frankfurt explicitly publishes catheter-based left atrial appendage closure (LAA occluder) as an option for selected patients with atrial fibrillation and high bleeding risk or intolerance of anticoagulation.
UKE publishes catheter-based left atrial appendage closure with dedicated interdisciplinary case review for selected patients who require an alternative to long-term anticoagulation.
Heidelberg University Hospital publishes a dedicated catheter-based left atrial appendage closure pathway for selected patients with atrial fibrillation and high bleeding risk.
Leipzig's cardiac catheterization laboratory explicitly lists interventional closure of the left atrial appendage among its catheter-based procedures.
University Medical Center Mainz publishes a dedicated left-atrial-appendage occluder pathway for selected patients with atrial fibrillation when long-term anticoagulation is problematic because of clinically relevant bleeding risk.
LMU Klinikum explicitly publishes left atrial appendage (LAA) occlusion among its catheter-based structural-heart procedures for selected patients.
TUM Klinikum publishes percutaneous left atrial appendage closure with dedicated device-based pathways for selected patients who require an alternative to long-term anticoagulation.
UKM explicitly lists left atrial appendage occlusion (LAA occluder) among the complex catheter-based structural-heart procedures supported by its interventional echocardiography team.
Charité identifies acute and chronic leukemias as major clinical focuses of its hematology department and publishes dedicated acute-leukemia specialist pathways alongside transplant and cellular therapies.
University Hospital Bonn lists diagnosis and treatment of acute and chronic leukemias among the clinical focuses of its hematology service, together with transplant and cellular-therapy capability.
Cologne's CAR-T and hematologic-neoplasms programs document treatment pathways for leukemia, including acute lymphoblastic leukemia and cellular therapy for selected patients.
The Dresden hematology program explicitly lists acute and chronic leukemias, including AML, ALL, CML and CLL, and integrates specialist diagnostics, systemic therapy and cellular-treatment options where indicated.
University Hospital Düsseldorf identifies leukemia diagnosis and treatment as a major focus of its hematology service and publishes dedicated leukemia pathways within its university tumor center.
University Hospital Erlangen states that Medical Clinic 5 diagnoses and treats leukemias using modern systemic, transplant and cellular-therapy approaches according to the individual disease pathway.
University Hospital Essen publishes a dedicated specialist clinic for acute leukemias and myelodysplastic syndromes and states that it treats all forms of acute leukemia within its hematology program.
Frankfurt's hematology and oncology service explicitly lists acute and chronic leukemias among its clinical treatment focuses and includes stem-cell transplantation within the department.
Freiburg publishes a dedicated leukemia competence center covering diagnostics and treatment of acute and chronic leukemias, with links to stem-cell transplantation and cellular therapies when indicated.
UKE's transplant center explicitly lists leukemia among the diseases treated with its hematology, transplantation and cellular-therapy pathways.
Heidelberg University Hospital publishes dedicated acute-leukemia and hematology services, including remote second-opinion options and stem-cell transplantation expertise.
Leipzig's hematology and cell-therapy department explicitly lists acute and chronic leukemias and myeloid neoplasms among its treatment spectrum.
The Mainz Leukemia and Lymphoma Center is the central UCT contact point for malignant diseases of blood and hematopoietic tissue and explicitly lists acute and chronic leukemia programs.
LMU Klinikum publishes a dedicated acute-leukemia program for AML and ALL with modern diagnostics, allogeneic transplantation and cellular/immunotherapy options.
The UKM Hemato-Oncology Center explicitly lists acute leukemias among its principal treatment areas and integrates chemotherapy, stem-cell transplantation and cellular immunotherapy pathways.
The Tübingen ZZT explicitly lists leukemias among the diseases treated with cellular therapies and stem-cell transplantation, and Internal Medicine II publishes dedicated leukemia specialist clinics and clinical-study contacts.
ULLM documents specialist treatment of acute and chronic leukemias together with transplant and cellular-therapy services and interdisciplinary case review.
Charité’s memory services explicitly evaluate and treat Lewy-body dementia alongside Alzheimer’s disease, frontotemporal dementia and other cognitive disorders using neurological assessment, neuropsychology, imaging review and selected CSF biomarker testing.
Freiburg publishes dedicated Lewy-body disease information covering the characteristic cognitive, visual, sleep and parkinsonian symptoms, medication sensitivity, cholinesterase-inhibitor treatment in selected patients and non-drug multidisciplinary care.
Heidelberg explicitly includes dementia with Lewy bodies in its specialist outpatient clinic for atypical parkinsonian syndromes and documents diagnostic differentiation using clinical assessment, MRI, CSF and selected functional imaging when appropriate.
Charité's neuromuscular services focus on genetic muscle diseases and muscular dystrophies, while its cardiology program specifically lists LGMD among muscular dystrophies evaluated for cardiac involvement. This supports subtype-focused neuromuscular and cardiac review rather than generic dystrophy care.
Freiburg's EURO-NMD/DGM-certified neuromuscular program explicitly includes limb-girdle muscular dystrophies and provides genetic diagnostics, muscle imaging, neurophysiology, selected biopsy, cardiology, pulmonology, orthopedics and multidisciplinary second-opinion review across pediatric and adult care.
Heidelberg's DGM-certified neuromuscular clinic evaluates myopathies and muscular dystrophies with detailed neurological assessment, ENG/EMG and broader specialist diagnostics, with pediatric neuromuscular care also available through the same center network.
NCT Heidelberg publishes a certified Liver Cancer Center with interdisciplinary surgical, medical-oncology, gastroenterology, radiotherapy and interventional-radiology input.
Saarland University Hospital's visceral-surgery department publishes German Cancer Society certification for its liver cancer center.
Leipzig lists a dedicated University Liver Tumor Center within its organ-cancer network, combining hepatology, hepatobiliary surgery, oncology and multidisciplinary treatment planning for liver malignancies.
Mainz publishes a certified Visceral Oncology Center that includes a certified liver cancer center and integrates hepatology, oncology and visceral/transplant surgery.
Charité publishes a dedicated European Metastasis Center in which metastatic disease is reviewed by multidisciplinary teams and treatment is selected according to the primary cancer and the complete metastatic pattern, with liver metastases listed as a dedicated organ pathway.
Freiburg publishes specialist liver-metastasis care combining liver surgery with multimodal systemic and interventional options and separately documents local ablation and SIRT for selected liver metastases.
Heidelberg publishes a dedicated liver-metastasis pathway and states that liver resection is an individualized decision based on the underlying cancer, overall disease extent and local liver findings through its interdisciplinary liver clinic.
Charité's Liver Center documents complex liver surgery, minimally invasive and robot-assisted liver resections, and certification as a DGAV Center of Excellence for liver surgery within an interdisciplinary liver-cancer program.
Freiburg publishes a dedicated liver and biliary surgery clinic for liver tumors and liver metastases and a Fast Track pathway for hepatobiliary operations, including minimally invasive approaches when appropriate.
Heidelberg's Section of Liver Surgery documents approximately 300–350 liver resections per year, open and laparoscopic liver surgery, and standardized multidisciplinary assessment and treatment planning for liver resection.
Charité documents stereotactic radiotherapy and CyberKnife for selected organ metastases, including liver metastases, with high-dose precision treatment and respiratory tracking for moving targets.
Freiburg documents stereotactic radiotherapy and radiosurgery in a small number of fractions for selected extracranial targets and uses modern image-guided high-precision radiation techniques.
UKE explicitly describes extracranial stereotactic body radiotherapy for small lesions in the liver and other body sites, including image guidance with sub-millimeter precision and respiratory-motion management.
Heidelberg documents CyberKnife stereotaxy for liver tumors including hepatocellular carcinoma, intrahepatic cholangiocarcinoma and oligometastatic liver disease, with real-time motion compensation.
Charité's European Metastasis Center documents local ablative techniques including radiofrequency ablation and microwave ablation within multidisciplinary treatment of selected metastatic disease.
Freiburg documents CT-guided radiofrequency and microwave ablation for selected tumors and explains technical selection according to target size, location and perfusion.
Heidelberg University Hospital's interdisciplinary Liver Cancer Center explicitly includes radiofrequency ablation among local interventional-radiology treatment options for liver cancer.
University Hospital Augsburg publishes an inpatient Lutetium-177 PSMA radioligand-therapy pathway for selected metastatic prostate-cancer patients after interdisciplinary indication review, including PSMA PET/CT before treatment.
Charité publishes a dedicated Lu-177 PSMA radioligand-therapy pathway for selected patients with advanced metastatic prostate cancer after specialist assessment.
University Hospital Cologne explicitly publishes PSMA-targeted radionuclide therapy using Lu-177 PSMA as a treatment option within its nuclear-medicine prostate-cancer program.
University Hospital Dresden publishes a dedicated PSMA-ligand-therapy pathway using Lutetium-177 PSMA for selected patients with metastatic prostate cancer, including pre-treatment review, PSMA imaging and inpatient treatment planning.
UKE Nuclear Medicine explicitly publishes treatment of metastatic prostate tumors with Lu-177 PSMA within its clinical nuclear-medicine treatment spectrum.
Heidelberg Nuclear Medicine publishes PSMA-targeted radioligand therapy for metastatic prostate cancer and explicitly describes Lu-177 as a radionuclide used in the PSMA-RLT pathway.
Leipzig publishes a dedicated therapy clinic for radioligand treatment with Lu-177-PSMA and a separate PSMA PET/CT pathway used in prostate-cancer assessment.
LMU Klinikum publishes a dedicated Lu-177 PSMA radioligand-therapy pathway for selected patients with metastatic prostate cancer after specialist assessment and confirmation of sufficient PSMA expression.
University Hospital Augsburg publishes a DKG-certified Lung Cancer Center with a mesothelioma unit and interdisciplinary diagnostics and treatment across all stages of lung cancer.
Charité publishes a dedicated lung-cancer program for NSCLC and SCLC with multidisciplinary treatment, comprehensive molecular diagnostics, chemotherapy, immunotherapy and targeted therapy and participates in the national network for genomic medicine in lung cancer.
Freiburg publishes a dedicated lung-cancer and thoracic-tumor program integrating oncology, thoracic surgery, pulmonology and radiation oncology and identifies itself as a center of the National Network Genomic Medicine Lung Cancer.
The NCT-linked Lung Cancer Center at Thoraxklinik Heidelberg publishes an interdisciplinary pathway covering thoracic surgery, oncology, radiation therapy, pulmonology and second opinions.
Saarland University Hospital publishes a dedicated University Lung Cancer Center in which pneumology, thoracic surgery and other specialist departments coordinate multidisciplinary lung-cancer treatment.
Leipzig publishes a dedicated University Lung Cancer Center coordinating prevention, diagnostics, surgery, systemic therapy, radiotherapy and follow-up through an interdisciplinary thoracic-oncology team.
University Medical Center Mainz publishes a German Cancer Society-certified Lung Cancer Center combining pneumology, oncology, thoracic surgery, radiology, radiation oncology and pathology for individualized lung-cancer treatment.
Charité publishes dedicated lymphoma treatment and specialist consultation pathways and lists lymphoma among the principal clinical focuses of its hematology department.
University Hospital Bonn lists diagnosis and treatment of lymphomas, including highly malignant non-Hodgkin lymphoma, among its hematology clinical focuses and links this care with its cell-therapy and transplant program.
University Hospital Cologne documents a DKG-certified hematologic-neoplasms center treating malignant lymphomas and providing access to advanced therapies including CAR-T for selected patients.
University Hospital Dresden explicitly lists Hodgkin and non-Hodgkin lymphomas among the diseases treated by its hematology and cell-therapy service, which also provides autologous transplantation and CAR-T therapy for selected patients.
University Hospital Düsseldorf publishes malignant lymphoma as a dedicated clinical focus covering Hodgkin and non-Hodgkin lymphoma, with specialized hematology treatment and cellular-therapy pathways.
Medical Clinic 5 explicitly lists malignant lymphomas among the blood-system cancers it treats and provides systemic therapy, stem-cell transplantation and CAR-T therapy for selected patients.
University Hospital Essen publishes dedicated lymphoma expertise and treatment pathways for malignant lymphomas, with specialist outpatient care and access to cellular and transplant therapies for selected disease courses.
University Medicine Frankfurt lists Hodgkin and non-Hodgkin lymphoma among the principal diseases treated by Medical Clinic 2, alongside its established hematology and stem-cell-transplantation program.
Freiburg's Interdisciplinary Tumor Center lists a dedicated Lymphoma Center alongside hematology, stem-cell transplantation and cellular-therapy services.
UKE explicitly lists malignant lymphoma and Hodgkin lymphoma within its transplant and cell-therapy treatment spectrum, including CAR-T and allogeneic transplantation for selected pathways.
Heidelberg University Hospital and NCT publish specialist lymphoma consultation, hematology and advanced-treatment pathways including second opinions and stem-cell transplantation where clinically appropriate.
The UKS cellular-therapy program describes specialist treatment of aggressive lymphomas including DLBCL and CAR-T therapy for selected relapsed disease.
Leipzig explicitly lists non-Hodgkin lymphoma, Hodgkin lymphoma and CLL among the lymphoid neoplasms treated by its hematology and cell-therapy department.
The Mainz Leukemia and Lymphoma Center explicitly includes malignant lymphomas and integrates disease-specific hematology, stem-cell transplantation and cellular therapy services.
LMU Medical Clinic III publishes malignant lymphoma as a major clinical focus and integrates lymphoma care with cellular immunotherapy and transplant expertise.
UKM explicitly lists aggressive and indolent lymphomas among the core treatment areas of its hemato-oncology center, with integrated stem-cell transplantation and CAR-T options for selected disease pathways.
The Tübingen ZZT explicitly lists lymphomas among its cellular-therapy indications, while Internal Medicine II maintains a dedicated lymphoma clinic and lymphoma board.
ULLM documents treatment of Hodgkin and non-Hodgkin lymphomas and integrates hematology, transplant and CAR-T services for selected patients.
The Cologne Eye Clinic explicitly lists macular-hole formation among conditions treated with vitreoretinal procedures such as vitrectomy and publishes a dedicated retinal-surgery pathway.
Freiburg's retinology service lists macular hole among its vitreoretinal and macular-surgery indications and provides OCT and other specialist retinal imaging.
UKE's retinal service documents macular hole within its retinal-disease spectrum and describes OCT assessment of vitreofoveal traction that can be associated with macular-hole development.
Bonn's neuromuscular and rare-disease teams publish a dedicated McArdle clinical review describing PYGM genetics, second-wind phenomenon, CK/genetic confirmation, rhabdomyolysis risk and long-term exercise/self-management, and identify the Bonn Neuromuscular Center as a specialist point of care.
Freiburg explicitly lists glycogen storage disease type V (McArdle) among the metabolic myopathies evaluated by its exercise-based myopathy diagnostics service, working together with the Neuromuscular Clinic.
Heidelberg's adult inherited metabolic disease clinic explicitly treats carbohydrate-metabolism disorders including glycogenoses and provides a structured transition and metabolic-medicine pathway for adults with inherited metabolic disease.
Charité operates a dedicated Skin Tumor Center with melanoma pathways and an active clinical-trial portfolio covering perioperative and advanced melanoma settings.
Freiburg documents specialist dermato-oncology for malignant melanoma, including modern intravenous immunotherapy, mutation-guided oral targeted therapy and multidisciplinary skin-cancer care.
Heidelberg publishes a dedicated skin-tumor center with interdisciplinary melanoma care, tumor-board review and current melanoma clinical studies across stage-specific settings.
Charité publishes dedicated brain and skull-base tumor consultations and states that it treats meningiomas at different intracranial locations, with treatment planning discussed in an interdisciplinary tumor conference and skull-base board and surgical and radiotherapy options considered according to the case.
Freiburg publishes a dedicated meningioma page and neuro-oncology program covering observation, surgical treatment, postoperative care and radiotherapy considerations for selected recurrent or faster-growing tumors.
Heidelberg's Skull Base Center identifies meningiomas as a common skull-base tumor entity and describes interdisciplinary treatment planning with modern microsurgery, neuronavigation, intraoperative imaging, neuromonitoring and collaboration with radiation oncology for complex cases.
Charité publishes a dedicated Headache Center for diagnostic classification of headache and facial-pain disorders, optimisation of acute and preventive treatment, CGRP/CGRP-receptor antibody therapy, botulinum toxin for chronic migraine and intensified outpatient care for chronic headache and medication overuse.
Freiburg documents a DMKG-certified headache center, specialist treatment of chronic migraine and medication-induced headache and a neurological botulinum-toxin clinic that treats chronic migraine with structured outpatient follow-up.
Heidelberg publishes a dedicated neurological headache clinic for treatment-resistant, unclear or complex headache disorders, individualized treatment plans, further diagnostics and botulinum-toxin therapy for chronic migraine.
Charité's rare-disease network lists a dedicated Center for Mitochondrial Diseases for adults, while its pediatric metabolic and neuromuscular services explicitly include mitochondriopathies and inherited energy-metabolism disorders.
Bonn explicitly lists mitochondrial diseases as a clinical specialty within its neuromuscular service, provides specialized biochemical and molecular-genetic diagnostics and muscle/cardiac imaging, and is part of the German mitoNET network with registry and study access.
Freiburg's MetabERN-certified metabolic center explicitly treats mitochondrial energy-metabolism disorders including oxidative-phosphorylation, pyruvate-metabolism and citric-acid-cycle defects, supporting diagnosis and multidisciplinary pediatric metabolic care.
Heidelberg's DGM-certified neuromuscular clinic explicitly includes mitochondriopathies and offers neurological examination, ENG/EMG and broader specialist diagnostics for complex neuromuscular and multisystem disease.
Augsburg's structural-heart program explicitly lists catheter-based mitral and tricuspid clipping and describes edge-to-edge repair for mitral regurgitation.
DHZC explicitly lists transcatheter edge-to-edge repair (TEER) of the mitral and tricuspid valves using systems such as MitraClip or PASCAL within its structural-heart program.
University Hospital Cologne publishes catheter-based mitral-valve repair with MitraClip / transcatheter edge-to-edge repair within its dedicated mitral and tricuspid valve service.
UKD publishes a dedicated mitral/tricuspid valve program that explicitly describes transcatheter edge-to-edge repair (TEER), including MitraClip, for selected patients with mitral regurgitation.
The Frankfurt structural-heart program explicitly lists catheter-based mitral valve repair using transcatheter edge-to-edge repair (TEER) among its treatment options for mitral regurgitation.
UKE explicitly publishes transcatheter edge-to-edge repair (TEER / clipping) for mitral regurgitation within its catheter-based heart-valve program.
Heidelberg publishes catheter-based mitral-valve repair with MitraClip for selected patients with mitral regurgitation within its interventional valve program.
Saarland University Hospital publishes non-surgical catheter-based repair of mitral and tricuspid regurgitation using edge-to-edge clipping, including the Pascal system.
Leipzig's structural-intervention program explicitly publishes percutaneous mitral-valve repair using the MitraClip system for selected high-risk patients with mitral regurgitation.
University Medical Center Mainz publishes a dedicated catheter-based mitral-valve program using MitraClip and other transcatheter repair techniques for selected patients after specialist Heart Team assessment.
LMU Klinikum explicitly publishes catheter-based clipping / edge-to-edge repair for mitral and tricuspid regurgitation within its structural-heart and valve program.
TUM Klinikum's invasive-cardiology service explicitly lists catheter-based clip treatment for mitral and tricuspid valve regurgitation among its structural-heart interventions.
UKM's interventional echocardiography service explicitly lists catheter-based edge-to-edge repair (TEER) for mitral and tricuspid valve disease among its structural-heart procedures.
DHZC documents a DGK-certified mitral valve center with high-volume surgical reconstruction, valve replacement and catheter-based MitraClip/TEER treatment in an interdisciplinary structural-heart program.
UKE documents mitral-valve surgery together with catheter-based MitraClip treatment for selected higher-risk patients and evaluates transcatheter therapy in relation to surgical treatment.
Freiburg explicitly treats MOGAD in its inflammatory-CNS neuroimmunology clinic, offering first diagnosis, differential diagnosis, second opinions and immunotherapy indication or escalation; complex MOGAD treatment changes can also be reviewed in its interdisciplinary Neuroimmunboard.
Heidelberg publishes a dedicated MOG-IgG-associated encephalomyelitis/MOGAD pathway covering specialist antibody diagnostics, MRI and CSF evaluation, acute relapse treatment and long-term immunotherapy, with an established neuroimmunology section treating MOGAD as distinct from NMOSD and MS.
UKD's vascular neurosurgery program explicitly lists bypass surgery for Moya-Moya among its neurovascular treatments and states that it treats cerebral and spinal vascular disease across age groups, with interdisciplinary care for children and adolescents when required.
Tübingen operates a dedicated Moyamoya and cerebral bypass center within its Center for Rare Diseases. The center states that adult Moyamoya patients are generally treated in Tübingen, offers a specialist Moyamoya/bypass consultation and reports experience with around 100 bypass procedures per year.
Freiburg publishes an established certified CAR-T program and explicitly lists ide-cel and cilta-cel for selected patients with relapsed or refractory multiple myeloma.
Heidelberg University Hospital publishes a dedicated Myeloma Center and lists conventional systemic therapy, high-dose therapy with autologous stem-cell transplantation, CAR-T cell therapy, allogeneic transplantation, radiotherapy, supportive care and clinical trials within its multiple-myeloma program.
Ulm University Hospital publishes a dedicated leukemia-lymphoma-myeloma center treating multiple myeloma and documents autologous/allogeneic stem-cell transplantation and CAR-T cellular therapy within its specialist hematology program.
Charité documents specialist diagnosis and treatment of multiple sclerosis and other chronic inflammatory CNS diseases, including a DMSG-recognised MS Schwerpunktzentrum and individualized immunotherapy decisions.
Freiburg publishes a dedicated neuroimmunology clinic for MS and related inflammatory CNS diseases covering first diagnosis, differential diagnosis, second opinions, initiation or escalation of immunotherapy and symptom-management counselling.
Heidelberg Neurology documents a neuroimmunology outpatient clinic recognised as an MS center by the German Multiple Sclerosis Society and specialist care for chronic inflammatory CNS diseases including MS.
Charité explicitly lists multiple system atrophy among its atypical Parkinson syndromes and combines specialist movement-disorder treatment with neurogenic autonomic-dysfunction assessment including tilt-table testing and supportive aids/social-care planning.
Freiburg documents specialist differentiation of atypical Parkinson syndromes and describes advanced nuclear-medicine approaches that can help distinguish MSA from idiopathic Parkinson’s disease, PSP and corticobasal degeneration in selected patients.
Heidelberg operates a dedicated atypical-Parkinson clinic that explicitly treats MSA-P and documents MSA-P/MSA-C differentiation, autonomic symptoms, MRI, tilt-table testing and selected functional imaging for diagnostic clarification.
Charité publishes a certified interdisciplinary myasthenia center with antibody testing, electrophysiological diagnostics, differential diagnosis of related neuromuscular syndromes, second opinions and comprehensive treatment of myasthenia gravis.
Freiburg documents a specialist myasthenia pathway covering AChR, MuSK, LRP4 and Titin antibody testing, repetitive nerve stimulation, pyridostigmine, immunosuppression, thymectomy coordination and escalation with IVIG, plasmapheresis or immunoadsorption when clinically necessary.
Heidelberg publishes a dedicated myasthenia gravis outpatient pathway and notes that the disease can affect ocular, bulbar and limb muscles and can progress to crisis requiring temporary intensive care.
Charité operates a dedicated interdisciplinary Myositis Center for inflammatory muscle diseases, with structured neurological, rheumatological, dermatological, radiological and neuropathological evaluation including EMG/ENG, CK, myositis autoantibodies, genetics and muscle biopsy.
Freiburg's neuromuscular clinic provides diagnosis, treatment and counseling for acquired inflammatory and genetic myopathies using EMG/ENG, high-resolution muscle ultrasound/MRI, blood testing, genetics and muscle biopsy, with interdisciplinary review of complex cases.
Heidelberg's DGM-certified neuromuscular clinic evaluates myopathies with electrophysiology, muscle imaging and biopsy, while its neuroimmunology clinic explicitly includes myositis and offers complex diagnostic and therapeutic pathways for inflammatory neurological disease.
Charité's neuromuscular program explicitly includes myotonic dystrophies among genetic muscle diseases and provides specialist differential diagnosis and further ambulatory or inpatient work-up. Charité cardiology also has a dedicated pathway for muscular dystrophies with cardiac involvement, explicitly including DM1 and DM2.
Freiburg's Neuromuscular Center provides adult and pediatric muscle clinics, genetics and multidisciplinary coordination with cardiology, pneumology and rehabilitation; its pediatric rare-disease program explicitly lists myotonic syndromes including myotonic dystrophy.
Heidelberg's DGM-certified neuromuscular outpatient clinic evaluates myopathies with ENG/EMG, muscle imaging and biopsy where relevant and works closely with cardiology, sport medicine and other specialties, supporting multidisciplinary review of hereditary muscle disease.
NCT Heidelberg publishes a dedicated neuroendocrine-tumor consultation and multidisciplinary treatment pathway involving oncology, endocrinology, gastroenterology, surgery, nuclear medicine, pathology, radiology and radiation oncology.
Ulm University Hospital publishes a dedicated GEP-NEN pathway covering classification, CT/MRI and receptor PET/CT diagnostics as well as multidisciplinary treatment options for neuroendocrine neoplasms.
UKE operates a dedicated interdisciplinary Neurofibromatosis Clinic and Day Clinic for children, adolescents and adults with NF1 and schwannomatosis. Its published services include molecular-genetic diagnostics, genetic counseling, neuropsychological assessment, tumor volumetry, infusion treatment and an interdisciplinary NF board; UKE states that the program follows around 1,700 patients per year.
Charité publishes outpatient services for neuromyelitis optica within its chronic inflammatory CNS and neuroimmunology clinics, providing diagnosis, treatment counseling, longitudinal monitoring and second opinions for critical therapeutic decisions.
Freiburg's specialist inflammatory-CNS clinic explicitly treats NMOSD and MOGAD and provides first diagnosis, differential diagnosis, second opinions, immunotherapy selection and treatment escalation within a dedicated neuroimmunology service.
Heidelberg publishes a dedicated NMOSD disease pathway covering AQP4-IgG testing, MRI of brain and spinal cord, CSF diagnostics, acute relapse treatment, long-term immunotherapy, laboratory monitoring and follow-up through its neuroimmunology clinic.
Düsseldorf's Skull Base Center publishes a dedicated antibody-therapy pathway for NF2-associated vestibular schwannoma using bevacizumab, with outpatient administration through neurosurgery. This supports a precise referral role for selected progressive vestibular schwannomas where systemic therapy is being considered.
UKE explicitly treats NF2-related schwannomatosis within its dedicated NF/schwannomatosis center. The published program includes molecular-genetic diagnostics, genetic counseling, longitudinal follow-up, neurophysiology, tumor volumetry, infusion therapies and an interdisciplinary NF board; UKE reports around 1,700 NF/schwannomatosis patients per year.
Charité documents a specialist neurosurgical service for disorders of the CSF system, including hydrocephalus and normal pressure hydrocephalus with shunt-based care and follow-up.
Freiburg operates a dedicated CSF Center for hydrocephalus and normal pressure hydrocephalus and documents objective gait assessment after CSF drainage as part of specialist NPH evaluation.
Heidelberg documents diagnosis and treatment of hydrocephalus with MRI/CT, permanent shunts with programmable valve systems and endoscopic ventriculostomy for selected obstructive hydrocephalus.
University Hospital Augsburg's PET Center explicitly lists F-18 FDG PET/CT among the PET examinations provided by its nuclear-medicine department.
Charité publishes dedicated FDG PET tumor-diagnostics information and lists oncology applications including several FDG-avid cancer types.
University Hospital Cologne explains clinical F-18 FDG PET/CT for cancer imaging and publishes PET/CT appointment pathways that explicitly include FDG examinations.
University Medicine Frankfurt publishes a dedicated FDG PET/CT tumor-diagnostics pathway for suitable malignancies including lymphoma and selected lung, head-and-neck and gastrointestinal cancers.
Freiburg publishes an oncology FDG PET/CT pathway for suspicious findings, initial staging and therapy/follow-up assessment.
UKE Nuclear Medicine explicitly lists whole-body F-18 FDG PET/CT for detection of tumors or inflammation as part of its clinical oncology imaging service.
Heidelberg Nuclear Medicine publishes clinical PET/CT using F-18 FDG for localization of metabolically active tumors and metastases and for evaluating treatment response.
Saarland University Hospital's PET/CT Center explicitly lists FDG PET/CT for metabolic imaging used particularly in cancer, inflammation and selected neurological diagnostic pathways.
Leipzig publishes a dedicated oncology FDG PET/CT preparation and appointment pathway through its university nuclear-medicine department.
Mainz describes FDG as its common PET tracer and publishes PET/CT for tumor staging, treatment-response assessment and recurrence evaluation across suitable malignancies.
LMU Klinikum publishes a dedicated patient pathway for F-18 FDG PET/CT used in tumor detection, staging and assessment of treatment response for suitable malignancies.
Charité publishes a dedicated European Competence Center for Ovarian Cancer within its gynecologic tumor center, with specialized diagnostics, surgery, systemic treatment, genetics, clinical studies and survivorship services.
University Hospital Essen lists ovarian carcinoma as a dedicated focus of its Gynecologic Cancer Center, which is part of the West German Cancer Center (WTZ).
Heidelberg publishes a dedicated ovarian-cancer pathway covering ultrasound and imaging, CA-125, multidisciplinary planning, complex cytoreductive surgery, chemotherapy, maintenance treatment, genetic counseling and recurrence review.
Augsburg explicitly lists ICD and CRT implantation, leadless pacemakers and conduction-system pacing within its dedicated cardiac-catheter and heart-rhythm program.
DHZC publishes dedicated pacemaker and defibrillator services and a separate International Patients pathway for self-paying patients from abroad.
University Hospital Cologne's electrophysiology service explicitly provides pacemaker, implantable cardioverter-defibrillator (ICD) and cardiac resynchronization device implantation for appropriate rhythm disorders and heart failure.
University Hospital Düsseldorf publishes a dedicated rhythmology and device clinic covering pacemakers, implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy (CRT).
University Medicine Frankfurt publishes pacemaker and implantable-defibrillator therapy as part of its treatment program for cardiac rhythm disorders.
UKE publishes dedicated cardiac device therapy covering pacemakers, implantable cardioverter-defibrillators (ICD) and related cardiac stimulation systems.
Heidelberg's Heart Rhythm Center explicitly provides pacemaker, ICD and cardiac resynchronization device implantation and follow-up.
Saarland University Hospital publishes implantation and follow-up of pacemakers, ICDs and CRT systems, including leadless and subcutaneous devices and revision/extraction expertise.
Leipzig publishes the complete spectrum of pacemaker and defibrillator therapy, including leadless pacemakers, ICDs, subcutaneous ICDs, CRT and device follow-up.
Mainz's Rhythmology department publishes implantable-device therapy with pacemakers and defibrillators as a core specialist focus alongside catheter ablation.
LMU Klinikum explicitly publishes implantation and follow-up of pacemakers, implantable cardioverter-defibrillators (ICD) and cardiac resynchronization devices.
TUM Klinikum publishes a dedicated pacemaker, ICD and CRT clinic with device implantation and structured follow-up within its rhythmology service.
UKM's rhythmology department explicitly provides modern pacemaker and implantable cardioverter-defibrillator therapy and operates a dedicated pacemaker/ICD clinic.
Augsburg's certified interdisciplinary vascular center lists peripheral arterial occlusive disease among its principal treatment areas and provides surgical and endovascular revascularization pathways.
UKE documents integrated vascular surgery, endovascular treatment and angiology for peripheral arterial disease, including balloon/stent revascularization and open surgical options for selected severe disease.
Saarland University Hospital publishes PAD care through vascular surgery, angiology and interventional radiology, combining risk-factor management, exercise, balloon/stent treatment and surgery according to the vascular anatomy and clinical severity.
Leipzig publishes PAD treatment ranging from balloon angioplasty and stenting to atherectomy, thrombolysis, thrombectomy and open bypass or endarterectomy through its interdisciplinary vascular center.
Mainz explicitly publishes revascularization for peripheral arterial occlusive disease, including limb-salvage and pedal bypass strategies for severe disease and diabetic foot ischemia.
University Hospital Augsburg publishes a dedicated pancreatic cancer center within its certified visceral-oncology network.
Freiburg publishes a certified pancreatic cancer center with a dedicated interdisciplinary pancreatic clinic and tumor board spanning surgery, oncology, gastroenterology, radiation oncology and radiology.
Heidelberg publishes a dedicated Pancreatic Cancer Center with multidisciplinary review across visceral surgery, oncology, gastroenterology, radiology, pathology and radiation oncology.
Saarland University Hospital's visceral-surgery department publishes German Cancer Society certification for its pancreatic cancer center.
Leipzig publishes a dedicated Pancreas Center covering diagnosis, treatment and follow-up of pancreatic diseases including ductal pancreatic adenocarcinoma, with an interdisciplinary tumor conference.
Mainz's certified Visceral Oncology Center includes a German Cancer Society-certified pancreatic cancer module with coordinated gastroenterology, oncology and visceral surgery.
Charité documents specialist movement-disorder diagnostics, Parkinson medication adjustment, indications and follow-up for deep brain stimulation, and escalation to Duodopa or apomorphine pump therapy.
Freiburg publishes a specialist Parkinson pathway including medication-based treatment, apomorphine and levodopa pump therapy and multidisciplinary evaluation for advanced treatment including deep brain stimulation.
Düsseldorf Urology publishes a dedicated renal-tumor pathway describing staging with CT and surgical treatment including organ-preserving partial resection and minimally invasive kidney surgery in selected patients.
Freiburg publishes a dedicated renal-cell-carcinoma pathway covering CT/MRI and biopsy, partial and radical nephrectomy, ablation, targeted therapy and immunotherapy within its urologic-oncology service.
Heidelberg Urology publishes integrated urologic-oncology care within NCT and documents kidney-preserving and robotic renal surgery, including complex kidney malignancies.
Freiburg publishes specialist pediatric hematology/oncology and blood stem-cell transplantation services for selected childhood cancers and hematologic diseases.
UKE publishes a DKG-certified pediatric oncology center specializing in cancers and blood diseases of children and adolescents, including leukemias, lymphomas, solid tumors and brain tumors.
Heidelberg University Hospital publishes a specialist pediatric oncology, hematology and immunology clinic integrated with the Hopp Children's Cancer Center, providing care for the full spectrum of childhood cancers and severe blood diseases.
Leipzig publishes a dedicated pediatric oncology and hematology department with specialist outpatient care and additional stem-cell-transplantation and cellular-therapy pathways.
Mainz publishes a certified pediatric oncology center within its university cancer center, with dedicated pediatric hematology/oncology inpatient, outpatient, day-clinic and follow-up services.
LMU Klinikum publishes a dedicated Pediatric Oncology Center at the Dr. von Hauner Children's Hospital for children and adolescents with blood cancers, solid tumors and other pediatric malignancies.
Heidelberg's interdisciplinary Skull Base Center explicitly treats meningiomas of the anterior, middle and posterior skull base. Its neurosurgery service describes skull-base meningioma surgery with intraoperative neuromonitoring, navigation, intraoperative MRI/CT/ultrasound and interdisciplinary coordination with radiation oncology and other specialties, providing a directly documented pathway for complex petroclival-region meningiomas.
Charité documents pituitary adenomas within its brain and skull-base tumor program, including transsphenoidal surgery and interdisciplinary endocrine and radiation-oncology care where appropriate.
Freiburg documents a dedicated pituitary-surgery program with interdisciplinary neuroendocrine evaluation and transsphenoidal surgery for pituitary and sellar tumors.
Heidelberg documents interdisciplinary diagnosis of pituitary adenomas, endocrine testing, visual assessment and transsphenoidal surgery, with medical-first treatment for many prolactinomas.
Charité documents specialist outpatient pathways for hereditary CMT/HMSN, immune-mediated polyneuropathies including CIDP and vasculitic/MGUS neuropathies, amyloid polyneuropathy and neurological complications of cancer treatment, allowing cause-specific review rather than a one-size-fits-all neuropathy approach.
Freiburg documents expertise in peripheral nerve disease, clinical neurophysiology with nerve-conduction studies and EMG, nerve and muscle ultrasound, neurological physiotherapy for polyneuropathy and a specialist clinic for inflammatory diseases of the peripheral nervous system.
Heidelberg publishes a dedicated polyneuropathy disease page and a detailed electrophysiology SOP for chronic distal-symmetric polyneuropathy, including ENG/EMG classification and targeted laboratory work-up for treatable causes. The neuromuscular service also supports advanced peripheral-nerve diagnostics and interdisciplinary review.
Charité's pediatric metabolic medicine service explicitly lists Pompe disease among lysosomal storage disorders and provides multidisciplinary outpatient care for children and adolescents with inherited metabolic disease.
Bonn explicitly operates a Pompe Therapy Center within its neuromuscular service and documents outpatient enzyme-replacement therapy for patients with late-onset Pompe disease, alongside specialized biochemical, molecular-genetic, imaging and muscle/nerve diagnostic capabilities.
Heidelberg's DGM-certified neuromuscular clinic evaluates myopathies with detailed neurophysiology, muscle imaging, laboratory testing and biopsy, and Heidelberg also documents current clinical-trial activity in pediatric Pompe disease, supporting a specialist metabolic-myopathy pathway.
UKE's vascular outpatient clinic explicitly states that it treats cerebral vasculitides alongside rare and complicated cerebrovascular diseases and difficult stroke questions, and it also provides specialist consultation for referring physicians.
Heidelberg's Center for Rare Neurological Diseases explicitly lists cerebral angiitis among its rare neurovascular focus areas and describes specialist adult outpatient care supported by neuroradiology, neuropathology and interdisciplinary disease-specific case discussion.
Charité’s movement-disorders program explicitly treats atypical Parkinson syndromes including PSP and offers specialist differential diagnosis with MRI, PET/SPECT, CSF, neuropsychology and other selected diagnostics according to the clinical question.
Freiburg documents specialist diagnosis and treatment of atypical Parkinson syndromes including PSP and describes selected functional imaging that can help differentiate PSP, MSA and corticobasal degeneration from idiopathic Parkinson’s disease.
Heidelberg publishes a dedicated clinic for atypical Parkinson syndromes that explicitly includes progressive supranuclear palsy and a clinical overview describing PSP phenotypes, eye-movement dysfunction, postural instability, akinesia and cognitive features.
University Hospital Augsburg publishes a DKG-certified Prostate Cancer Center within its Comprehensive Cancer Center, with multidisciplinary diagnosis and treatment across all phases of prostate cancer.
Charité publishes a DKG-certified interdisciplinary prostate-cancer center covering diagnosis, staging and individualized treatment including surgery and other multidisciplinary treatment strategies.
University Hospital Bonn publishes an interdisciplinary prostate-cancer pathway with tumor-board review and surgical, radiotherapy, systemic and nuclear-medicine options according to the individual clinical situation.
University Hospital Cologne publishes a certified prostate center offering multidisciplinary treatment options for localized prostate cancer, including active surveillance, surgery, radiotherapy and specialist consultation.
Dresden's urology service describes a German Cancer Society-certified prostate-cancer center within its uro-oncology center, with modern diagnostics, minimally invasive and radical surgery, systemic therapy and multidisciplinary review for urologic malignancies.
University Hospital Essen publishes a dedicated prostate-cancer pathway covering active surveillance, open or robot-assisted prostatectomy, radiotherapy, systemic therapy and radioligand treatment as clinically appropriate.
University Medicine Frankfurt publishes an interdisciplinary uro-oncology center covering diagnosis, treatment and follow-up of prostate cancer, with coordinated urology, oncology, radiology, pathology and radiation-oncology review and a certified prostate-cancer program.
Freiburg publishes a dedicated Prostate Cancer Center with interdisciplinary diagnostic and treatment planning, a urogenital tumor board and cooperation across urology, radiation oncology, internal oncology and pathology.
NCT Heidelberg publishes a DKG-certified Prostate Cancer Center with interdisciplinary participation from urology, oncology, radiotherapy, nuclear medicine, pathology and radiology.
Saarland University Hospital publishes a dedicated Prostate Cancer Center with interdisciplinary tumor-board review, defined treatment pathways and individualized treatment planning within its uro-oncology cancer center.
Leipzig publishes an interdisciplinary Prostate Cancer Center covering guideline-based diagnosis, treatment and follow-up with coordinated urology, radiation oncology, pathology, nuclear medicine and oncology partners.
University Medical Center Mainz publishes a university uro-oncology center covering prostate cancer from diagnosis through treatment and follow-up, with interdisciplinary review and a DKG-certified prostate-cancer program.
LMU Klinikum publishes an interdisciplinary prostate center covering prostate cancer diagnosis, treatment and follow-up, including surgery, radiotherapy, systemic treatment and advanced imaging pathways.
The UKM Prostate Cancer Center publishes DKG certification, interdisciplinary treatment planning and the full treatment spectrum for prostate cancer across disease stages.
University Hospital Dresden operates University Proton Therapy Dresden within its radiation-oncology and OncoRay program, with active patient care, tumor-specific indications and dedicated patient registration for adult and pediatric proton treatment.
The West German Proton Therapy Centre Essen is part of University Medicine Essen and provides pencil-beam-scanning proton therapy for selected adult and pediatric tumors, with a dedicated case-management pathway for national and international patients.
Heidelberg University Hospital operates HIT for highly precise proton and heavy-ion treatment of selected cancers and publishes direct patient treatment-enquiry and consultation routes through the center.
Charité Nuclear Medicine lists peptide receptor radionuclide therapy for neuroendocrine tumors among its specialist inpatient nuclear-medicine treatment areas.
University Hospital Essen documents DOTATOC therapy among its specialist open-radionuclide treatments, providing current institutional evidence of a receptor-targeted radionuclide-therapy program.
Heidelberg Nuclear Medicine explicitly lists PRRT for neuroendocrine tumors, including Lutathera and DOTATOC therapy, within its specialist nuclear-medicine treatment program.
Ulm Nuclear Medicine publishes peptide receptor radionuclide therapy for somatostatin-receptor-positive neuroendocrine tumors using Lu-177-labelled DOTATATE and explains that adequate receptor expression and organ function are prerequisites.
The Augsburg Prostate Cancer Center explicitly lists PSMA PET-CT among its diagnostic services for detecting or differentiating prostate-cancer metastases, alongside MRI and fusion biopsy pathways.
Charité publishes a dedicated Ga-68 PSMA PET service for prostate cancer and explains how PET is combined with CT or MRI for anatomical localization.
University Hospital Cologne publishes a dedicated PSMA PET/CT diagnostic pathway using Ga-68 and F-18 PSMA tracers for sensitive imaging of prostate-cancer tissue.
University Medicine Frankfurt publishes a dedicated Ga-68 PSMA PET/CT pathway for staging and recurrence assessment in prostate cancer, including patient preparation and examination workflow.
UKE Nuclear Medicine explicitly lists Ga-68 PSMA PET/CT for prostate cancer within its clinical PET/CT diagnostic program.
Heidelberg Nuclear Medicine publishes dedicated PSMA imaging with Ga-68 PSMA-11 and F-18 PSMA-1007, including patient preparation and PET/CT workflow for prostate cancer.
Saarland University Hospital's PET/CT Center explicitly lists PSMA PET/CT for imaging prostate-cancer cells using a PSMA-targeted radiotracer.
Leipzig's nuclear-medicine service publishes dedicated PSMA-ligand PET/CT scheduling and preparation for patients with prostate cancer.
Mainz's nuclear-medicine PET/CT center explicitly offers PSMA PET/CT for prostate cancer and accepts Ga-68 PSMA examination requests through its PET/CT pathway.
LMU Klinikum states that Ga-68 PSMA-ligand PET/CT is its standard imaging method for confirming PSMA expression before radioligand therapy and uses PSMA PET/CT within its prostate-cancer diagnostic pathway.
Düsseldorf's Bladder Cancer Center lists robot-assisted radical cystectomy together with perioperative systemic treatment and interdisciplinary management.
Essen Urology lists radical cystectomy for bladder cancer among the procedures performed with its Da Vinci Xi robotic system.
Freiburg documents radical cystectomy for bladder cancer together with reconstructive urinary diversion including ileal conduit and neobladder options, and also publishes robot-assisted cystectomy within its urologic surgery program.
Heidelberg Urology explicitly publishes Da Vinci-assisted radical cystectomy for selected malignant bladder tumors and bladder-replacement procedures following cystectomy.
Essen Nuclear Medicine documents inpatient risk-adapted radioiodine therapy for differentiated thyroid carcinoma, including preparation, post-therapy imaging and structured follow-up.
Freiburg Nuclear Medicine documents inpatient I-131 radioiodine therapy for differentiated thyroid carcinoma after surgery and in selected recurrent or metastatic iodine-avid disease, with thyroid-cancer follow-up through its thyroid clinic.
Freiburg publishes multidisciplinary pediatric and rare-disease expertise across genetics, metabolic medicine, neurology, surgery and other subspecialties.
Children's UKE explicitly identifies rare, complex and unexplained diseases as a major focus and combines pediatric subspecialties, transplant programs, metabolic medicine, neurology and rare congenital disease care within a tertiary children's hospital.
Heidelberg's children's center links multiple pediatric subspecialties with the university Center for Rare Diseases, including dedicated rare blood, immune, neurologic and metabolic disease pathways for complex pediatric cases.
University Medical Center Mainz states that its Center for Rare Diseases has been certified as a Type A reference center and its pediatric hospital publishes dedicated rare-disease services including PAEDSE and rare metabolic disease programs.
The Cologne Eye Clinic publishes a dedicated retinal-surgery service covering modern outpatient and inpatient vitreoretinal procedures, laser treatment and intravitreal injections.
Freiburg operates a dedicated retinology service with OCT, OCT angiography, autofluorescence, fluorescein and indocyanine-green angiography plus vitreoretinal surgical pathways.
UKE publishes a broad retinal-disease service covering retinal detachment, macular disease, diabetic retinal disease, vitreomacular interface disorders, OCT diagnostics and vitreoretinal treatment.
Cologne explicitly documents retinal vein occlusion, macular edema after RVO, OCT and angiographic diagnostics, repeated intravitreal VEGF-inhibitor or corticosteroid treatment and laser therapy when indicated.
Freiburg has a dedicated retinology service with OCT and angiographic imaging and publishes specialist material on retinal vascular occlusion and anti-VEGF treatment of macular edema.
UKE lists retinal vein occlusion among its retinal vascular diseases and documents OCT, fluorescein angiography and intravitreal anti-VEGF treatment for edema associated with vascular occlusions.
Charité's headache research program explicitly includes clinical studies on reversible cerebral vasoconstriction syndrome (RCVS). Its neurology service also provides specialist outpatient assessment and inpatient treatment focused on acute headache syndromes and rare neurological disorders, supporting complex post-emergency RCVS diagnostic review and follow-up.
Charité publishes specialist diagnostics for painful hip prostheses and revision hip replacement with reconstruction of bone defects using advanced implant systems, including custom solutions in selected complex cases.
UKE explicitly publishes revision arthroplasty for hip and knee prostheses and evaluates loosening, infection, instability, dislocation, wear and unexplained pain after joint replacement.
University Hospital Augsburg publishes a dedicated robotic-urology service and explicitly lists radical prostatectomy among the procedures performed with the da Vinci X system.
Charité's prostate-cancer service explicitly offers minimally invasive robot-assisted da Vinci radical prostatectomy as one of its surgical treatment approaches.
University Hospital Bonn publishes Da Vinci Xi robot-assisted urologic surgery and explicitly lists radical prostatectomy among the procedures performed with the system.
University Hospital Cologne publishes robot-assisted radical prostatectomy with the Da Vinci system as a minimally invasive surgical option for prostate cancer within its urology program.
UKD documents a certified prostate-cancer service and robot-assisted minimally invasive surgery with the Da Vinci system; its COIP office coordinates elective treatment requests from abroad.
Erlangen Urology publishes a dedicated Da Vinci prostatectomy pathway, while the International Patient Office handles treatment recommendations and estimates for patients from abroad.
University Hospital Essen publishes robot-assisted prostatectomy with the Da Vinci system as a surgical option for selected patients with localized prostate cancer.
University Medicine Frankfurt Urology publishes robot-assisted radical prostatectomy with the Da Vinci system as a minimally invasive surgical option for prostate cancer within its specialized prostate program.
Freiburg publishes Da Vinci robot-assisted urologic surgery and prostate-cancer treatment within its urology program.
Heidelberg University Hospital publishes da Vinci robot-assisted radical prostatectomy as an established minimally invasive treatment for prostate cancer within its urology department.
Saarland University Hospital's German Da Vinci Center documents robot-assisted surgery for localized prostate cancer and radical prostatectomy within its long-running urologic robotic-surgery program.
University Medical Center Leipzig documents routine use of the da Vinci system for prostate surgery and lists robot-assisted radical prostatectomy among its laparoscopic and robotic urology procedures.
University Medical Center Mainz publishes a dedicated da Vinci prostatectomy pathway for prostate cancer and states that robot-assisted prostatectomy is part of its curative prostate-cancer treatment program.
LMU's prostate center documents radical prostatectomy with robot-assisted Da Vinci surgery and the hospital operates a central International Patient Office for case review and treatment planning.
TUM's certified prostate cancer center documents robot-assisted radical prostatectomy with the Da Vinci system and publishes a separate route for operations for patients from abroad.
The UKM Prostate Center explicitly publishes robot-assisted Da Vinci prostatectomy as a minimally invasive surgical option for prostate cancer.
Charité publishes a dedicated interdisciplinary sarcoma center for malignant soft-tissue and bone tumors, including extremity, abdominal, retroperitoneal and pelvic sarcomas, with sarcoma-conference review across surgical, medical-oncology, radiotherapy and reconstructive specialties.
Freiburg publishes an interdisciplinary sarcoma center for soft-tissue, bone and abdominal sarcomas; its soft-tissue sarcoma center has been certified by the German Cancer Society since March 2026.
The Heidelberg Sarcoma Center is DKG-certified for bone and soft-tissue sarcomas and publishes weekly interdisciplinary sarcoma boards involving orthopedic, visceral and plastic surgery, medical oncology, radiotherapy, radiology and pathology.
Charité documents selective internal radiotherapy (SIRT) with Y-90 microspheres for selected primary liver tumors and liver metastases, including angiographic preparation, test distribution imaging and inpatient radionuclide treatment.
University Hospital Essen lists SIRT as intra-arterial radionuclide therapy for liver tumors within its Nuclear Medicine treatment program and coordinates liver-tumor options through specialist services.
Freiburg documents SIRT for liver tumors and liver metastases in cooperation with interventional radiology, with inpatient preparation, angiography, Y-90 microsphere treatment and post-treatment SPECT/CT.
Heidelberg University Hospital documents selective internal radiotherapy using Y-90 glass or resin particles delivered by catheter angiography for selected primary and secondary liver tumors.
The WPE explicitly documents chordoma treatment with intensity-modulated pencil-beam proton therapy, states that chordomas are treated comparatively frequently, works within the DKG-certified Sarcoma Center of University Medicine Essen and provides case management for patients from abroad.
Heidelberg explicitly treats skull-base chordomas in its interdisciplinary Skull Base Center and combines modern skull-base surgery with HIT, where skull-base chordomas are listed indications for proton and carbon-ion radiotherapy.
WPE explicitly lists sarcomas of the skull base, including chondrosarcomas, among proton-treated indications and works within University Medicine Essen's sarcoma network.
Heidelberg explicitly lists skull-base chondrosarcomas in its interdisciplinary Skull Base Center and at HIT, combining skull-base surgery with proton and carbon-ion radiotherapy and long-standing clinical research in this diagnosis.
Heidelberg explicitly describes spheno-orbital meningioma as a skull-base meningioma that can grow predominantly within sphenoid bone, extend intradurally and infiltrate the orbit, causing exophthalmos and diplopia. Its certified Skull Base Center combines neurosurgery, ophthalmology, ENT, oral and maxillofacial surgery and radiation oncology, with dedicated optic-canal/orbit and reconstructive expertise.
Heidelberg's vascular and interventional neuroradiology service explicitly states that arteriovenous malformations of the brain or spinal cord can be treated endovascularly by embolization. The section offers the full spectrum of diagnostic and therapeutic neurointerventional procedures with close interdisciplinary cooperation, supporting multidisciplinary review of spinal AVM angiography, embolization and surgical options.
Heidelberg explicitly lists spinal gliomas and astrocytomas among its rare intramedullary spinal tumors and describes MRI-based assessment, microsurgical spinal-tumor treatment, continuous intraoperative neurophysiological monitoring and multidisciplinary cooperation with neuropathology, neuro-oncology and radiotherapy.
University Hospital Essen explicitly states that cavernous malformations can occur in or around the spinal cord and are then termed spinal cavernomas. Its neurosurgery and spine-surgery department manages vascular lesions with interventional neuroradiology, discusses cases interdisciplinarily and runs a dedicated cavernoma clinic with extensive cavernous-malformation experience.
Freiburg's vascular neurosurgery program covers vascular diseases of both the brain and spinal cord. Its dedicated dural AV fistula page identifies progressive or fluctuating leg paralysis as a typical spinal presentation and states that treatment is performed surgically or endovascularly with neuroradiology.
Heidelberg explicitly describes spinal arteriovenous fistulas, venous-congestive spinal-cord edema and interdisciplinary treatment. Its published pathway states that typical grade-I spinal AV fistulas are preferentially treated microsurgically, with endovascular techniques used according to anatomy.
Heidelberg explicitly lists intramedullary ependymomas among its specialized spinal-tumor indications and describes microsurgical resection performed by experienced neurosurgeons with intraoperative neurophysiological monitoring. The program is integrated with neuropathology, neuro-oncology and radiotherapy.
Freiburg has a dedicated hemangioblastoma/VHL program that explicitly treats spinal-cord hemangioblastomas and describes microsurgical removal, intraoperative neuromonitoring, routine ICG videoangiography, selected minimally invasive approaches, preoperative embolization for selected larger solid tumors and multidisciplinary VHL care.
Heidelberg's dedicated spinal-tumor program explicitly lists meningiomas as intradural-extramedullary tumors and describes microsurgical resection as treatment of choice. The program reports approximately 100 spinal-tumor operations annually and uses intraoperative neuromonitoring, navigation and interdisciplinary neuro-oncology support.
Charité's certified pediatric neuromuscular center explicitly treats spinal muscular atrophy and participates in SMA longitudinal treatment evaluation through SMArtCARE, with multidisciplinary expertise in respiratory, swallowing, orthopedic and other neuromuscular complications.
Freiburg's rare-disease neuromuscular center explicitly includes spinal muscular atrophy and related syndromes, multidisciplinary case review, updated SMA pathways and SMArtCARE/clinical-study activity covering children and, in several programs, adults.
Heidelberg explicitly provides supraregional assessment and second opinions for severe, unclear or rare neuromuscular diseases including spinal muscular atrophy, and its clinical-study program includes adult 5q-SMA treatment and sequencing questions.
Heidelberg explicitly lists spinal Neurinome among intradural-extramedullary tumors, describes their origin from nerve-root sensory fascicles and states that microsurgical resection is the treatment of choice. Its spinal tumor program reports approximately 100 operations per year and uses intraoperative neuromonitoring, navigation and interdisciplinary neuro-oncology support.
Freiburg explicitly documents lumbar spinal stenosis treated with minimally invasive or microsurgical decompression and cervical stenosis treated with microsurgical decompression with disc prosthesis or fusion in selected cases.
UKE publishes an interdisciplinary University Spine Center for degenerative, inflammatory, traumatic and neoplastic spinal disease, while its Neurosurgery department explicitly includes spinal-canal stenosis among the conditions it treats with modern minimally invasive and image-guided techniques.
Charité publishes a dedicated spine-surgery section providing operative and conservative treatment for degenerative disorders, trauma, deformity, inflammatory disease and spinal tumors.
UKE publishes a specialist spine-surgery service covering cervical, thoracic and lumbar disease using open and minimally invasive approaches.
Heidelberg University Hospital publishes a dedicated university spine center offering conservative and operative treatment, including complex revision, deformity, tumor and minimally invasive spine surgery.
Saarland University Hospital publishes a specialist spine-therapy and spine-surgery service within its orthopedic department, with dedicated consultation and individualized treatment planning.
Leipzig publishes a DWG-certified maximum-care interdisciplinary spine center offering conservative, minimally invasive and operative treatment for congenital and acquired disorders across the cervical, thoracic and lumbar spine.
Mainz publishes a dedicated spine-surgery service with conservative, interventional and operative treatment concepts for degenerative disease, fractures, deformity, infection and spinal tumors.
LMU Klinikum publishes a dedicated spine-surgery program covering the entire spine with operative and conservative treatment for degenerative disease, spinal stenosis, instability, trauma, tumors and congenital conditions.
Freiburg publishes a dedicated SIH/CSF Center pathway with brain and spine MRI, dynamic digital-subtraction and CT myelography, non-targeted and targeted epidural patching, catheter embolization for selected CSF-venous fistulas and neurosurgical closure of localized spinal CSF leaks.
Heidelberg's neuroradiology service publishes a dedicated blood-patch pathway for low-CSF-pressure syndrome, including pre-treatment brain and spine MRI, selected CT myelography, CT-guided leak localization and targeted autologous blood injection.
RWTH Aachen's Medical Clinic IV publishes dedicated allogeneic stem-cell transplantation capacity within its hematology and oncology department.
Charité publishes a dedicated allogeneic stem-cell transplantation service with specialist pre-transplant consultation and treatment pathways for selected high-risk leukemias, lymphomas and other hematologic diseases.
University Hospital Bonn states that its dedicated center performs both autologous and allogeneic stem-cell transplantation as part of its hematology and cellular-therapy program.
Dresden publishes both allogeneic and autologous stem-cell transplantation within its cell-therapy program, including transplantation for leukemia, lymphoma, myeloma and selected other hematologic disorders.
University Hospital Düsseldorf documents long-running autologous and allogeneic blood stem-cell transplantation programs within its hematology department together with specialized inpatient and follow-up pathways.
Medical Clinic 5 publishes bone-marrow and blood stem-cell transplantation as part of its comprehensive hematology treatment spectrum for malignant blood disorders.
University Hospital Essen operates a dedicated allogeneic stem-cell transplantation program within its hematology clinic, with specialized transplant wards, coordination and outpatient follow-up.
Frankfurt Medical Clinic 2 documents stem-cell transplantation as part of its hematology treatment spectrum for malignant and non-malignant hematologic disease.
Freiburg publishes dedicated allogeneic stem-cell transplantation services, outpatient follow-up and an international medical-services pathway for hematology and oncology.
UKE publishes autologous and allogeneic hematopoietic stem-cell transplantation, including related and unrelated donor pathways, as core services of its dedicated transplant center.
Heidelberg publishes allogeneic, autologous and outpatient autologous stem-cell transplantation as dedicated hematology procedures within its university transplant section.
Saarland University Hospital publishes a dedicated stem-cell transplant unit and patient information for allogeneic stem-cell transplantation, with separate transplant coordination contacts.
Leipzig lists both allogeneic and autologous stem-cell transplantation within the treatment spectrum of its hematology and cell-therapy department.
The Mainz center publishes both autologous and allogeneic hematopoietic stem-cell transplantation pathways within its dedicated cellular-immunotherapy and transplant program.
LMU Medical Clinic III publishes all established allogeneic stem-cell transplantation procedures, including haploidentical transplantation, within its acute-leukemia treatment program.
UKM operates a dedicated bone-marrow-transplant center with autologous and allogeneic stem-cell transplantation programs for adult hematologic disease and separate pediatric transplantation capability.
Tübingen publishes a dedicated center for children and adults that performs autologous and allogeneic hematopoietic stem-cell transplantation and provides specialized transplant follow-up.
Ulm publishes an allogeneic blood stem-cell and bone-marrow transplantation unit offering family, unrelated, haploidentical and cord-blood donor pathways, with JACIE certification.
University Hospital Würzburg describes a major stem-cell transplantation center treating leukemia, lymphoma, myeloma and related hematological diseases.
Freiburg's neuroimmunology network explicitly includes Stiff-Person syndrome among rare disorders reviewed for differential diagnosis and therapy escalation through its interdisciplinary Neuroimmunboard and second-opinion pathway.
Heidelberg's Center for Rare Neurological Diseases explicitly lists Stiff-Person syndrome among rare CNS immunopathies, while its neurology service documents dedicated Stiff-Person expertise and an electrophysiology SOP for specialized diagnostic testing.
Charité explicitly lists Sturge-Weber among the neurocutaneous syndromes managed in its interdisciplinary pediatric neurology clinic and documents access to pediatric neurosurgery and pediatric ophthalmology/neuro-ophthalmology for disease complications.
Freiburg explicitly lists Sturge-Weber syndrome among the rare and complex epilepsies treated by its comprehensive epilepsy center, which offers multimodal diagnostics, neurostimulation and epilepsy-surgery pathways for selected patients.
Freiburg lists syringomyelia as a dedicated neurosurgical specialty, describes the spinal-cord syrinx and impaired cerebrospinal-fluid circulation as central to the condition, and publishes a dedicated Syringomyelia outpatient consultation within its Neurosurgery department.
Heidelberg publishes a dedicated spinal-malformations pathway that identifies syringomyelia as a major condition, documents MRI, electrophysiology and selected urodynamic assessment, and describes individualized spinal-cord surgery with microscopy and intraoperative neurophysiological monitoring.
Charité publishes a dedicated TACE pathway for highly vascularized liver tumors, including HCC, with pre-treatment imaging review, selective catheter treatment, inpatient care and repeat assessment.
Freiburg documents transarterial chemoembolization for primary and secondary liver tumors and states that the procedure is performed more than 200 times per year within its specialist liver and interventional-radiology services.
Heidelberg University Hospital's Liver Cancer Center explicitly lists TACE among the local interventional-radiology treatments available for liver cancer within its interdisciplinary HCC program.
RWTH Aachen's structural-heart section explicitly lists TAVI for severe aortic stenosis, including multiple access approaches and valve-in-valve treatment.
University Hospital Augsburg explicitly lists transfemoral TAVI in its cardiac catheter center and describes its heart center as a certified structural-valve program for transcatheter aortic and mitral interventions.
DHZC publishes a dedicated TAVI program within its Structural Heart Interventions Program and an International Patients pathway for treatment enquiries from abroad.
University Hospital Cologne publishes a dedicated transcatheter aortic-valve implantation (TAVI) program with interdisciplinary Heart Team assessment and a specialized catheter-based aortic-valve pathway.
University Hospital Düsseldorf publishes a dedicated TAVI program and aortic-valve clinic for catheter-based aortic-valve replacement within its structural-heart service.
University Hospital Essen publishes a dedicated transcatheter aortic-valve implantation (TAVI) pathway with pre-procedure assessment, inpatient treatment, follow-up and a named TAVI coordination service within its certified valve center.
The University Heart and Vascular Center Frankfurt explicitly lists transcatheter aortic-valve implantation (TAVI) among its catheter-based valve treatments for aortic stenosis.
UKE's University Heart and Vascular Center publishes transcatheter aortic-valve implantation (TAVI) as a dedicated catheter-based valve treatment performed by an interdisciplinary heart team.
Heidelberg University Hospital publishes a dedicated TAVI service and coordinator within its cardiology and structural-heart program.
Saarland University Hospital publishes a catheter-based aortic-valve program and states that its heart-valve center has been certified as a TAVI center by the German Cardiac Society since 2019.
Leipzig's cardiology department publishes a dedicated structural-heart program with transcatheter aortic valve implantation and hybrid-room cooperation with cardiac surgery.
University Medical Center Mainz publishes an interventional heart-valve program with a dedicated TAVI program and specialist leadership for transcatheter aortic-valve treatment.
LMU Klinikum publishes a dedicated structural-heart clinic and explicitly provides transcatheter aortic-valve implantation (TAVI) for selected patients with aortic-valve disease.
University Hospital Münster documents catheter-based structural-heart interventions including transcatheter aortic-valve implantation (TAVI) within its interventional echocardiography and valve program, and publishes dedicated TAVI coordination for patients.
University Hospital Würzburg publishes a dedicated aortic-valve / TAVR consultation within its specialist heart services.
Düsseldorf Urology publishes a dedicated testicular-tumor clinic and describes itself as a European reference center for the treatment of testicular cancer, with a specialist focus on advanced germ-cell tumors.
Freiburg Urology publishes a dedicated testicular-tumor pathway covering ultrasound, AFP/HCG/LDH tumor markers, staging imaging, orchiectomy, chemotherapy, selected radiotherapy and retroperitoneal lymph-node dissection.
Heidelberg University Urology publishes testicular cancer within its malignant testicular-disease and integrated urologic-oncology program, with interdisciplinary cancer treatment pathways linked to the NCT.
Augsburg has a dedicated adult Hydrocephalus, Chiari and Tethered Cord program. The hospital explicitly states that it treats classic and occult tethered-cord syndrome in adults and offers minimally invasive detethering, making it relevant for diagnostic review and adult surgical candidacy.
Freiburg's pediatric neurosurgery program describes tethered cord in children with spina bifida occulta and spinal dysraphism and emphasizes early neurosurgical assessment to determine the appropriate timing of surgery. This is specifically a pediatric referral pathway.
Freiburg publishes a dedicated thyroid carcinoma and endocrine tumor center with separate clinical pathways for papillary/follicular, medullary and anaplastic thyroid carcinoma and a thyroid tumor board.
Heidelberg publishes an interdisciplinary thyroid-cancer pathway with endocrine surgery and individualized tumor-board treatment, including differentiated and other thyroid-cancer subtypes.
Charité's functional neurosurgery and pain-therapy service documents interventional treatment for treatment-refractory trigeminal neuralgia, including ablative neurosurgical approaches.
Freiburg documents trigeminal neuralgia within its vascular compression syndrome program and describes microvascular decompression after unsuccessful medical treatment, with alternative specialist procedures including stereotactic radiation in selected cases.
Heidelberg documents specialist treatment of trigeminal neuralgia, including microvascular decompression for a vessel-nerve conflict and ablative approaches such as thermocoagulation for selected treatment-refractory cases.
Heidelberg explicitly lists tuberculum sellae meningioma among common skull-base meningiomas and describes optic-canal decompression, transcranial surgery and fully endoscopic transnasal approaches for selected anterior skull-base and sellar-region tumors. Its certified Skull Base Center combines neurosurgery with ENT, ophthalmology, neuroradiology and radiation oncology and uses neuronavigation, intraoperative imaging and neuromonitoring.
Charité publishes a certified TSC special clinic that follows more than 100 patients and coordinates interdisciplinary care with more than ten specialties, including neurology, dermatology, cardiology and pulmonology, with imaging, mTOR-inhibitor treatment and long-term surveillance.
Freiburg's comprehensive epilepsy center explicitly lists tuberous sclerosis complex among the rare and complex epilepsies it treats and offers multimodal diagnostics, medication therapy, neurostimulation and epilepsy-surgery pathways for selected patients.
UKE states that its neuropediatric service is a certified tuberous-sclerosis center and provides genetic diagnostics, long-term pediatric neurology care and advanced epilepsy pathways in close multidisciplinary cooperation.
Augsburg documents medical and operative fibroid treatment and explicitly lists myomectomy-related gynecologic care together with uterine-fibroid embolization as available treatment options.
Charité publishes uterine-fibroid embolization as a non-operative interventional-radiology treatment pathway for selected patients.
UKE publishes a dedicated fibroid and bleeding-disorders clinic that evaluates uterine fibroids and discusses medical, operative and radiologic treatment options according to symptoms, fibroid burden and fertility plans.
Heidelberg University Hospital publishes a dedicated Fibroid Center within general gynecology and provides individualized treatment planning for uterine fibroids, including operative care when appropriate.
Leipzig's interdisciplinary Fibroid Center documents open and laparoscopic surgery, uterine-artery embolization and MR-guided focused-ultrasound treatment, with interdisciplinary selection of the appropriate pathway.
Mainz publishes a dedicated fibroid clinic that follows patients from diagnosis through individualized treatment planning and offers uterus-preserving myomectomy or hysterectomy depending on symptoms, fibroid burden and patient goals.
LMU Klinikum explicitly lists uterine fibroids within its general gynecology program and specialist outpatient pathway for benign gynecologic disease.
Freiburg operates a dedicated retinology service with OCT, OCT angiography, autofluorescence, angiography and vitreoretinal surgical expertise for macular-interface disease.
UKE publishes a dedicated vitreofoveal-traction pathway covering fundus examination, OCT, observation, selected intravitreal treatment and vitrectomy when clinically indicated.
Freiburg publishes dedicated VHL clinics in neurosurgery and nephrology and coordinates genetics, ophthalmology, radiology, urology and other specialties. Its VHL program treats patients referred from Germany, Austria and Switzerland and explicitly describes CNS hemangioblastoma surveillance, microsurgery and current belzutifan review.
Charité's hepatology clinic explicitly treats inherited liver diseases including Wilson disease and can coordinate hepatic evaluation, anti-copper therapy and transplant-related assessment where necessary.
Freiburg's liver program explicitly treats hereditary liver disorders including Wilson disease and provides copper/ceruloplasmin laboratory diagnostics, supporting specialist hepatic assessment and long-term monitoring.
Heidelberg operates a dedicated Morbus Wilson specialist clinic that reports long-standing care of several hundred patients, national and international clinical-study participation and a rare-disease research focus specifically on Wilson disease.
Start by identifying the specialist program that matches the clinical question. Then prepare complete records, submit a concise treatment request and understand what the hospital quotation may include. Travel comes later.
Use verified hospital-source evidence to narrow the search to centers that document the treatment, diagnostic service or specialist pathway you are researching.
Browse verified centers →Prepare the diagnosis, recent reports, imaging in the requested format, pathology when relevant, treatment history and current medication list.
Medical records guide →Use the structured form for contact details and a short clinical summary. Treat in Germany and EMEX Medical can then clarify the case, required records and the appropriate secure route for documents.
Send treatment request →Compare the proposed clinical scope, inclusions, exclusions, advance payment and final settlement rather than a headline price alone.
Cost-estimate planning →Compare international-patient routes, contact details, languages and practical treatment-request workflows across verified university hospitals.
